Phorbol	O
ester-induced	O
mononuclear	O
cell	O
differentiation	O
is	O
blocked	O
by	O
the	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
kinase	I-protein
(	O
MEK	B-protein
)	O
inhibitor	O
PD98059	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
whether	O
the	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
(	O
MAPK	B-protein
)	O
signaling	O
pathway	O
contributes	O
to	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
-induced	O
mononuclear	O
differentiation	O
in	O
the	O
human	B-cell_line
myeloblastic	I-cell_line
leukemia	I-cell_line
ML-1	I-cell_line
cells	I-cell_line
.	O

Upon	O
TPA	O
treatment	O
,	O
the	O
activity	O
of	O
ERK1	B-protein
and	O
ERK2	B-protein
rapidly	O
increased	O
,	O
with	O
maximal	O
induction	O
between	O
1	O
and	O
3	O
h	O
,	O
while	O
ERK2	B-protein
protein	O
levels	O
remained	O
constant	O
.	O

The	O
activity	O
of	O
JNK1	B-protein
was	O
also	O
significantly	O
induced	O
,	O
with	O
JNK1	B-protein
protein	O
levels	O
increasing	O
moderately	O
during	O
exposure	O
to	O
TPA	O
.	O

Treatment	O
of	O
cells	O
with	O
PD98059	O
,	O
a	O
specific	O
inhibitor	O
of	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
kinase	I-protein
(	O
MEK	B-protein
)	O
,	O
inhibited	O
TPA-induced	O
ERK2	B-protein
activity	O
.	O

Furthermore	O
,	O
PD98059	O
completely	O
blocked	O
the	O
TPA-induced	O
differentiation	O
of	O
ML-1	B-cell_line
cells	I-cell_line
,	O
as	O
assessed	O
by	O
a	O
number	O
of	O
features	O
associated	O
with	O
mononuclear	O
differentiation	O
including	O
changes	O
in	O
morphology	O
,	O
nonspecific	O
esterase	B-protein
activity	O
,	O
phagocytic	O
ability	O
,	O
NADPH	B-protein
oxidase	I-protein
activity	O
,	O
mitochondrial	O
respiration	O
,	O
and	O
c-jun	B-RNA
mRNA	I-RNA
inducibility	O
.	O

We	O
conclude	O
that	O
activation	O
of	O
the	O
MEK	B-protein
/ERK	O
signaling	O
pathway	O
is	O
necessary	O
for	O
TPA-induced	O
mononuclear	O
cell	O
differentiation	O
.	O

Vol	NULL
.	NULL

10	NULL
,	NULL
307-315	NULL
,	NULL
May	NULL
1999	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Phorbol	NULL
Ester-induced	NULL
Mononuclear	NULL
Cell	NULL
Differentiation	NULL
Is	NULL
Blocked	NULL
by	NULL
the	NULL
Mitogen-activated	NULL
Protein	NULL
Kinase	NULL
Kinase	NULL
(	NULL
MEK	NULL
)	NULL
Inhibitor	NULL
PD98059	NULL
'	NULL
Hongchin	NULL
He	NULL
,	NULL
Xiantao	NULL
Wang	NULL
,	NULL
Myriam	NULL
Gorospe	NULL
,	NULL
Nikki	NULL
J.	NULL
Holbrook	NULL
,	NULL
and	NULL
Michael	NULL
A.	NULL
Trush*	NULL
Division	NULL
of	NULL
Toxicological	NULL
Sciences	NULL
,	NULL
Department	NULL
of	NULL
Environmental	NULL
Health	NULL
Sciences	NULL
,	NULL
School	NULL
of	NULL
Hygiene	NULL
and	NULL
Public	NULL
Health	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21205	NULL
[	NULL
H.	NULL
H.	NULL
,	NULL
M.	NULL
A.	NULL
T.	NULL
]	NULL
,	NULL
and	NULL
Gene	NULL
Expression	NULL
and	NULL
Aging	NULL
Section	NULL
,	NULL
National	NULL
Institute	NULL
on	NULL
Aging	NULL
,	NULL
NIH	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21224	NULL
[	NULL
X.	NULL
W.	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
N.	NULL
J.	NULL
H.	NULL
]	NULL
Abstract	NULL
The	NULL
purpose	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
evaluate	NULL
whether	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
signaling	NULL
pathway	NULL
contributes	NULL
to	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
-induced	NULL
mononuclear	NULL
differentiation	NULL
in	NULL
the	NULL
human	NULL
myeloblastic	NULL
leukemia	NULL
ML-1	NULL
cells	NULL
.	NULL

Upon	NULL
TPA	NULL
treatment	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
rapidly	NULL
increased	NULL
,	NULL
with	NULL
maximal	NULL
induction	NULL
between	NULL
1	NULL
and	NULL
3	NULL
h	NULL
,	NULL
while	NULL
ERK2	NULL
protein	NULL
levels	NULL
remained	NULL
constant	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
JNK1	NULL
was	NULL
also	NULL
significantly	NULL
induced	NULL
,	NULL
with	NULL
JNK1	NULL
protein	NULL
levels	NULL
increasing	NULL
moderately	NULL
during	NULL
exposure	NULL
to	NULL
TPA	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
with	NULL
PD98059	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
(	NULL
MEK	NULL
)	NULL
,	NULL
inhibited	NULL
TPA-induced	NULL
ERK2	NULL
activity	NULL
.	NULL

Furthermore	NULL
,	NULL
PD98059	NULL
completely	NULL
blocked	NULL
the	NULL
TPA-induced	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
a	NULL
number	NULL
of	NULL
features	NULL
associated	NULL
with	NULL
mononuclear	NULL
differentiation	NULL
including	NULL
changes	NULL
in	NULL
morphology	NULL
,	NULL
nonspecific	NULL
esterase	NULL
activity	NULL
,	NULL
phagocytic	NULL
ability	NULL
,	NULL
NADPH	NULL
oxidase	NULL
activity	NULL
,	NULL
mitochondrial	NULL
respiration	NULL
,	NULL
and	NULL
c-jun	NULL
mRNA	NULL
inducibility	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
MEK/ERK	NULL
signaling	NULL
pathway	NULL
is	NULL
necessary	NULL
for	NULL
TPA-induced	NULL
mononuclear	NULL
cell	NULL
differentiation	NULL
.	NULL

Introduction	NULL
Cell	NULL
differentiation	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
an	NULL
orchestrated	NULL
series	NULL
of	NULL
genetically	NULL
controlled	NULL
events	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
AP-1	NULL
,	NULL
°	NULL
composed	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
Received	NULL
1/12/98	NULL
;	NULL
revised	NULL
3/9/98	NULL
;	NULL
accepted	NULL
6/10/98	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

!	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grants	NULL
ESO3760	NULL
,	NULL
ESO7141	NULL
,	NULL
ESO8078	NULL
,	NULL
and	NULL
ES03819	NULL
from	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Environmental	NULL
Health	NULL
Sciences	NULL
,	NULL
NIH	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Division	NULL
of	NULL
Toxicological	NULL
Sciences	NULL
,	NULL
Department	NULL
of	NULL
Environmental	NULL
Health	NULL
Sciences	NULL
,	NULL
School	NULL
of	NULL
Hygiene	NULL
and	NULL
Public	NULL
Health	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
,	NULL
615	NULL
North	NULL
Wolfe	NULL
Street	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
21205	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
410	NULL
)	NULL
955-4712	NULL
;	NULL
Fax	NULL
:	NULL
(	NULL
410	NULL
)	NULL
955-0116	NULL
.	NULL

°	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
kinase	NULL
;	NULL
MEK	NULL
,	NULL
ERK	NULL
kinase	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoyl-phorbol-13-acetate	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transfer-	NULL
and/or	NULL
Fos	NULL
families	NULL
of	NULL
proteins	NULL
,	NULL
recognizes	NULL
and	NULL
binds	NULL
to	NULL
specific	NULL
DNA	NULL
sequences	NULL
and	NULL
stimulates	NULL
transcription	NULL
of	NULL
genes	NULL
responsive	NULL
to	NULL
diffentiation-inducing	NULL
agents	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
expression	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
,	NULL
as	NULL
well	NULL
as	NULL
AP-1	NULL
activity	NULL
,	NULL
were	NULL
induced	NULL
during	NULL
TPA-induced	NULL
monocyte/macrophage	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
HL-60	NULL
and	NULL
U937	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
AP-1	NULL
is	NULL
regulated	NULL
largely	NULL
through	NULL
its	NULL
phosphorylation	NULL
by	NULL
members	NULL
of	NULL
the	NULL
MAPK	NULL
(	NULL
8-11	NULL
)	NULL
.	NULL

MAPKs	NULL
constitute	NULL
a	NULL
superfamily	NULL
of	NULL
three	NULL
related	NULL
kinases	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
a	NULL
diverse	NULL
array	NULL
of	NULL
extracellular	NULL
stimuli	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

They	NULL
include	NULL
the	NULL
ERKs	NULL
(	NULL
15	NULL
)	NULL
,	NULL
the	NULL
JNKs	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
,	NULL
and	NULL
p38	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

ERK	NULL
,	NULL
JNK	NULL
,	NULL
and	NULL
p38	NULL
can	NULL
all	NULL
be	NULL
activated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
,	NULL
but	NULL
the	NULL
kinases	NULL
are	NULL
differentially	NULL
affected	NULL
by	NULL
certain	NULL
signals	NULL
.	NULL

For	NULL
example	NULL
,	NULL
ERKs	NULL
are	NULL
most	NULL
highly	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
mitogenic	NULL
stimulation	NULL
,	NULL
whereas	NULL
JNKs	NULL
and	NULL
p38	NULL
show	NULL
greater	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
cellular	NULL
stress	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
pathway	NULL
leading	NULL
to	NULL
ERK	NULL
activation	NULL
by	NULL
growth	NULL
factors	NULL
and	NULL
other	NULL
mitogens	NULL
has	NULL
been	NULL
studied	NULL
extensively	NULL
.	NULL

The	NULL
first	NULL
step	NULL
involves	NULL
activation	NULL
of	NULL
membrane-associated	NULL
tyrosine	NULL
kinases	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
sequential	NULL
activation	NULL
of	NULL
Ras	NULL
and	NULL
Raf	NULL
(	NULL
2	NULL
,	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Raf	NULL
then	NULL
phosphorylates	NULL
the	NULL
MEK	NULL
(	NULL
23	NULL
)	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
activates	NULL
ERK	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
some	NULL
treatments	NULL
,	NULL
such	NULL
as	NULL
TPA	NULL
,	NULL
appear	NULL
to	NULL
bypass	NULL
the	NULL
first	NULL
two	NULL
steps	NULL
,	NULL
entering	NULL
into	NULL
the	NULL
pathway	NULL
at	NULL
the	NULL
level	NULL
of	NULL
Raf	NULL
through	NULL
a	NULL
PKC-depend-ent	NULL
pathway	NULL
(	NULL
26-28	NULL
)	NULL
.	NULL

The	NULL
JNK	NULL
and	NULL
p38	NULL
kinases	NULL
are	NULL
activated	NULL
through	NULL
analogous	NULL
pathways	NULL
but	NULL
require	NULL
different	NULL
MEKs	NULL
for	NULL
their	NULL
phosphorylation	NULL
and	NULL
involve	NULL
distinct	NULL
upstream	NULL
mediators	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
initiating	NULL
events	NULL
involved	NULL
in	NULL
triggering	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
phosphorylation	NULL
cascades	NULL
are	NULL
poorly	NULL
under-stood	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
MAPK	NULL
cascades	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
sufficient	NULL
and	NULL
necessary	NULL
for	NULL
both	NULL
neuronal	NULL
differentiation	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
and	NULL
megakaryocytic	NULL
differentiation	NULL
(	NULL
31	NULL
)	NULL
.	NULL

MAPK	NULL
signaling	NULL
pathway	NULL
also	NULL
appears	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
mononuclear	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
,	NULL
where	NULL
ERK	NULL
and	NULL
JNK	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
activated	NULL
upon	NULL
treatment	NULL
with	NULL
TPA	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
expression	NULL
of	NULL
constitutively	NULL
active	NULL
MEK1	NULL
in	NULL
U937	NULL
cells	NULL
stimulated	NULL
JNK	NULL
activity	NULL
and	NULL
AP-1-mediated	NULL
transcriptional	NULL
activity	NULL
(	NULL
32	NULL
)	NULL
.	NULL

However	NULL
,	NULL
although	NULL
activation	NULL
of	NULL
MEK1	NULL
was	NULL
sufficient	NULL
to	NULL
inhibit	NULL
cell	NULL
growth	NULL
,	NULL
it	NULL
did	NULL
not	NULL
induce	NULL
the	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
into	NULL
macrophages	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
recent	NULL
studies	NULL
showed	NULL
that	NULL
the	NULL
total	NULL
ERK	NULL
activity	NULL
was	NULL
dramatically	NULL
reduced	NULL
during	NULL
TPA-induced	NULL
HL-60	NULL
cell	NULL
differentiation	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
exact	NULL
biological	NULL
function	NULL
of	NULL
the	NULL
MAPK	NULL
cascades	NULL
in	NULL
mononuclear	NULL
cell	NULL
differentiation	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

ase	NULL
;	NULL
NSE	NULL
,	NULL
nonspecific	NULL
esterase	NULL
;	NULL
SRBC	NULL
,	NULL
sheep	NULL
RBC	NULL
;	NULL
FBS	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
;	NULL
LDCL	NULL
,	NULL
lucigenin-derived	NULL
chemiluminescence	NULL
;	NULL
MBP	NULL
,	NULL
myelin	NULL
basic	NULL
protein	NULL
.	NULL

Block	NULL
by	NULL
PD98059	NULL
of	NULL
Mononuclear	NULL
Cell	NULL
Differentiation	NULL
A	NULL
.	NULL

Time	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
1	NULL
3	NULL
6	NULL
16	NULL
24	NULL
48	NULL
72	NULL
o-	NULL
Rime	NULL
-	NULL
>	NULL
B	NULL
.	NULL

Time	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
10	NULL
30	NULL
60	NULL
160	NULL
240	NULL
480	NULL
72	NULL
cri	NULL
:	NULL
-	NULL
aay	NULL
ans	NULL
am	NULL
ame	NULL
cae	NULL
dae	NULL
ane	NULL
C	NULL
*	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
1	NULL
3	NULL
6	NULL
16	NULL
240	NULL
48	NULL
72	NULL
oon	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Induction	NULL
of	NULL
ERK	NULL
by	NULL
TPA	NULL
.	NULL

A	NULL
,	NULL
kinetics	NULL
of	NULL
ERK2	NULL
activation	NULL
by	NULL
TPA	NULL
.	NULL

After	NULL
treatment	NULL
of	NULL
ML-1	NULL
cells	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
cellular	NULL
protein	NULL
extracts	NULL
were	NULL
isolated	NULL
and	NULL
immunoprecipitated	NULL
using	NULL
an	NULL
antibody	NULL
against	NULL
ERK2	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

ERK2	NULL
activity	NULL
in	NULL
the	NULL
immune	NULL
complex	NULL
was	NULL
measured	NULL
by	NULL
quantitating	NULL
the	NULL
incorporation	NULL
of	NULL
°°P	NULL
onto	NULL
MBP	NULL
after	NULL
resolving	NULL
the	NULL
kinase	NULL
assay	NULL
reactions	NULL
by	NULL
electrophoresis	NULL
in	NULL
12	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
.	NULL

B	NULL
,	NULL
Western	NULL
blot	NULL
analyses	NULL
of	NULL
ERK2	NULL
protein	NULL
expression	NULL
after	NULL
treatment	NULL
with	NULL
TPA	NULL
.	NULL

Cellular	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
and	NULL
blotting	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
an	NULL
antibody	NULL
recognizing	NULL
total	NULL
ERK2	NULL
.	NULL

C	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
activation	NULL
.	NULL

Blots	NULL
were	NULL
hybridized	NULL
with	NULL
Anti-Active	NULL
MAPK	NULL
antibody	NULL
,	NULL
which	NULL
specifically	NULL
recognizes	NULL
the	NULL
phosphorylated	NULL
and	NULL
activated	NULL
forms	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
ERK	NULL
signaling	NULL
pathway	NULL
in	NULL
another	NULL
model	NULL
of	NULL
mononuclear	NULL
cell	NULL
differentiation	NULL
,	NULL
that	NULL
of	NULL
the	NULL
human	NULL
myeloblastic	NULL
leukemic	NULL
cell	NULL
line	NULL
ML-1	NULL
.	NULL

Preliminary	NULL
studies	NULL
in	NULL
this	NULL
laboratory	NULL
showed	NULL
that	NULL
ML-1	NULL
cells	NULL
more	NULL
readily	NULL
undergo	NULL
monocytic	NULL
differentiation	NULL
in	NULL
response	NULL
to	NULL
TPA	NULL
than	NULL
HL-60	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
that	NULL
almost	NULL
50	NULL
times	NULL
less	NULL
TPA	NULL
is	NULL
required	NULL
to	NULL
induce	NULL
the	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
than	NULL
for	NULL
the	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
is	NULL
a	NULL
valuable	NULL
in	NULL
vitro	NULL
system	NULL
to	NULL
study	NULL
the	NULL
development	NULL
of	NULL
phenotypes	NULL
of	NULL
mono-cytes/macrophages	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
cell	NULL
differentiation	NULL
.	NULL

The	NULL
ML-1	NULL
cell	NULL
line	NULL
was	NULL
established	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
myeloblastic	NULL
leukemia	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Upon	NULL
treatment	NULL
with	NULL
DMSO	NULL
or	NULL
TPA	NULL
,	NULL
ML-1	NULL
cells	NULL
undergo	NULL
granulocytic	NULL
or	NULL
monocytic	NULL
cell	NULL
differentiation	NULL
,	NULL
respectively	NULL
(	NULL
36-39	NULL
)	NULL
.	NULL

Because	NULL
these	NULL
cells	NULL
differentiate	NULL
along	NULL
the	NULL
mononuclear	NULL
pathway	NULL
,	NULL
they	NULL
exhibit	NULL
features	NULL
typical	NULL
of	NULL
macrophages	NULL
,	NULL
including	NULL
morphology	NULL
,	NULL
nonspecific	NULL
esterase	NULL
activity	NULL
,	NULL
NADPH	NULL
oxidase	NULL
activity	NULL
,	NULL
specific	NULL
cell	NULL
surface	NULL
antigens	NULL
CD11b	NULL
and	NULL
CD14	NULL
,	NULL
phagocytic	NULL
ability	NULL
,	NULL
and	NULL
mitochondrial	NULL
respiration	NULL
(	NULL
36-39	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
ERK	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
TPA-induced	NULL
mononuclear	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
.	NULL

Results	NULL
Induction	NULL
of	NULL
ERK1	NULL
,	NULL
ERK2	NULL
,	NULL
and	NULL
JNK1	NULL
by	NULL
TPA	NULL
in	NULL
ML-1	NULL
cells	NULL
.	NULL

TPA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
both	NULL
ERK	NULL
and	NULL
JNK	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
ERK	NULL
and	NULL
JNK	NULL
were	NULL
stimulated	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
into	NULL
monocytes/	NULL
macrophages	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
these	NULL
kinases	NULL
was	NULL
quantitated	NULL
at	NULL
various	NULL
times	NULL
after	NULL
treatment	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
.	NULL

ERK2	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
cell	NULL
lysates	NULL
and	NULL
assayed	NULL
for	NULL
kinase	NULL
activity	NULL
by	NULL
measuring	NULL
its	NULL
ability	NULL
to	NULL
phosphorylate	NULL
MBP	NULL
.	NULL

As	NULL
A	NULL
.	NULL

Time	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
O1	NULL
3	NULL
6	NULL
16	NULL
24	NULL
48	NULL
72	NULL
GST-c-Jun	NULL
-	NULL
«	NULL
--	NULL
Ch	NULL
an	NULL
«	NULL
n	NULL
Oh	NULL
-	NULL
~	NULL
Fold	NULL
Induction	NULL
1.0	NULL
3.0	NULL
9.6	NULL
5.0	NULL
7.3	NULL
12.4	NULL
5.7	NULL
2.0	NULL
B	NULL
.	NULL

Time	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
_	NULL
1	NULL
3	NULL
6	NULL
16	NULL
24	NULL
48	NULL
72	NULL
INK	NULL
-	NULL
~~~	NULL
--	NULL
d	NULL
an	NULL
«	NULL
-	NULL
»	NULL
TD	NULL
UD	NULL
UL	NULL
Fold	NULL
Induction	NULL
1.0	NULL
1.6	NULL
3.0	NULL
2.7	NULL
27	NULL
5.4	NULL
5.5	NULL
4.9	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
JNK1	NULL
activation	NULL
and	NULL
protein	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
TPA	NULL
.	NULL

A	NULL
,	NULL
after	NULL
treatment	NULL
of	NULL
ML-1	NULL
cells	NULL
with	NULL
0.3	NULL
ng/m	NULL
!	NULL

TPA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
JNK1	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
an	NULL
immune	NULL
complex	NULL
kinase	NULL
assay	NULL
using	NULL
GST-c-Jun	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

B	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
JNK1	NULL
protein	NULL
expressions	NULL
in	NULL
ML-1	NULL
cells	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
after	NULL
treatment	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
.	NULL

shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
ERK2	NULL
rapidly	NULL
increased	NULL
in	NULL
response	NULL
to	NULL
TPA	NULL
with	NULL
a	NULL
6-fold	NULL
and	NULL
4-fold	NULL
induction	NULL
at	NULL
1	NULL
and	NULL
3	NULL
h	NULL
,	NULL
respectively	NULL
.	NULL

It	NULL
then	NULL
decreased	NULL
to	NULL
below	NULL
the	NULL
basal	NULL
levels	NULL
thereafter	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
time-dependent	NULL
activation	NULL
of	NULL
ERK2	NULL
was	NULL
further	NULL
illustrated	NULL
by	NULL
a	NULL
shift	NULL
to	NULL
a	NULL
slower-migrating	NULL
form	NULL
of	NULL
ERK2	NULL
,	NULL
as	NULL
observed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
representing	NULL
the	NULL
phosphorylated	NULL
,	NULL
and	NULL
therefore	NULL
activated	NULL
,	NULL
ERK2	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

To	NULL
ascertain	NULL
if	NULL
the	NULL
gel	NULL
mobility-retarded	NULL
bands	NULL
at	NULL
1	NULL
and	NULL
3	NULL
h	NULL
were	NULL
the	NULL
phosphorylated	NULL
and	NULL
activated	NULL
form	NULL
of	NULL
ERK2	NULL
and	NULL
to	NULL
evaluate	NULL
the	NULL
participation	NULL
of	NULL
ERK1	NULL
in	NULL
differentiation	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
antibody	NULL
recognizing	NULL
only	NULL
the	NULL
dually	NULL
phosphorylated	NULL
and	NULL
activated	NULL
ERK1	NULL
and	NULL
ERK2	NULL
.	NULL

Indeed	NULL
,	NULL
both	NULL
ERK1	NULL
and	NULL
ERK2	NULL
were	NULL
phosphorylated	NULL
,	NULL
exhibiting	NULL
maximal	NULL
phosphorylation	NULL
at	NULL
1-3	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
whereas	NULL
total	NULL
ERK2	NULL
protein	NULL
levels	NULL
remained	NULL
constant	NULL
throughout	NULL
the	NULL
TPA	NULL
treatment	NULL
period	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
the	NULL
JNK	NULL
after	NULL
TPA	NULL
treatment	NULL
of	NULL
ML-1	NULL
cells	NULL
was	NULL
then	NULL
examined	NULL
.	NULL

JNK1	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
cell	NULL
lysates	NULL
,	NULL
and	NULL
its	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
assessing	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
immunoprecipitates	NULL
to	NULL
phosphorylate	NULL
an	NULL
exoge-nous	NULL
substrate	NULL
,	NULL
GST-c-Jun	NULL
(	NULL
1-135	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
exposure	NULL
to	NULL
TPA	NULL
led	NULL
to	NULL
a	NULL
significant	NULL
time-dependent	NULL
increase	NULL
in	NULL
JNK1	NULL
activity	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
indicated	NULL
that	NULL
the	NULL
total	NULL
levels	NULL
of	NULL
JNK1	NULL
protein	NULL
increased	NULL
slightly	NULL
by	NULL
treatment	NULL
with	NULL
TPA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
moderate	NULL
elevation	NULL
of	NULL
JNK1	NULL
protein	NULL
level	NULL
may	NULL
partly	NULL
account	NULL
for	NULL
the	NULL
elevation	NULL
in	NULL
JNK1	NULL
kinase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
insufficient	NULL
to	NULL
mediate	NULL
the	NULL
dramatic	NULL
enhancement	NULL
in	NULL
JNK1	NULL
kinase	NULL
activity	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
Specific	NULL
MEK	NULL
Inhibitor	NULL
PD98059	NULL
on	NULL
TPA-mediated	NULL
ERK2	NULL
Activation	NULL
.	NULL

The	NULL
compound	NULL
PD98059	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
selectively	NULL
block	NULL
MEK	NULL
activation	NULL
and	NULL
,	NULL
conse-quently	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
ERK	NULL
without	NULL
affecting	NULL
the	NULL
JNK	NULL
or	NULL
p38	NULL
signaling	NULL
pathways	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
specificity	NULL
,	NULL
treatment	NULL
of	NULL
PC12	NULL
cells	NULL
with	NULL
PD98059	NULL
was	NULL
shown	NULL
to	NULL
inhibit	NULL
MEK	NULL
and	NULL
ERK	NULL
activations	NULL
by	NULL
nerve	NULL
growth	NULL
factor	NULL
and	NULL
to	NULL
block	NULL
neuronal	NULL
differentiation	NULL
(	NULL
42	NULL
)	NULL
.	NULL

PD98059	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
similarly	NULL
prevent	NULL
megakaryocytic	NULL
differentia-	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
-	NULL
0	NULL
1	NULL
3	NULL
6	NULL
1	NULL
3	NULL
60	NULL
3	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Inhibition	NULL
of	NULL
TPA-induced	NULL
ERK2	NULL
activity	NULL
by	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
.	NULL

Cellular	NULL
protein	NULL
extracts	NULL
were	NULL
isolated	NULL
after	NULL
addition	NULL
of	NULL
0.3	NULL
ng/m	NULL
!	NULL

TPA	NULL
to	NULL
ML-1	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
um	NULL
PD98059	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

Endogenous	NULL
ERK2	NULL
was	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
the	NULL
kinase	NULL
activity	NULL
associated	NULL
with	NULL
the	NULL
immune	NULL
complex	NULL
was	NULL
assayed	NULL
using	NULL
substrate	NULL
MBP	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

TPA	NULL
TPA	NULL
+	NULL
PD	NULL
Time	NULL
(	NULL
br	NULL
)	NULL
0	NULL
1	NULL
3	NULL
6	NULL
1	NULL
3	NULL
6	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
PD98059	NULL
on	NULL
JNK1	NULL
activity	NULL
.	NULL

Cellular	NULL
protein	NULL
extracts	NULL
were	NULL
isolated	NULL
after	NULL
addition	NULL
of	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
to	NULL
ML-1	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
um	NULL
PD98059	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

Endogenous	NULL
JNK1	NULL
was	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
the	NULL
kinase	NULL
activity	NULL
associated	NULL
with	NULL
the	NULL
immune	NULL
complex	NULL
was	NULL
assayed	NULL
using	NULL
GST-c-Jun	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

tion	NULL
of	NULL
human	NULL
erythroleukemia	NULL
K562	NULL
cells	NULL
induced	NULL
by	NULL
TPA	NULL
(	NULL
31	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
ERK	NULL
following	NULL
exposure	NULL
to	NULL
TPA	NULL
was	NULL
important	NULL
for	NULL
mononuclear	NULL
cell	NULL
differentiation	NULL
,	NULL
we	NULL
used	NULL
PD98059	NULL
to	NULL
pharmacologically	NULL
block	NULL
this	NULL
pathway	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
exposure	NULL
to	NULL
PD98059	NULL
led	NULL
to	NULL
a	NULL
2-fold	NULL
and	NULL
a	NULL
10-fold	NULL
reduction	NULL
in	NULL
TPA-activated	NULL
ERK2	NULL
activity	NULL
at	NULL
1	NULL
and	NULL
3	NULL
h	NULL
,	NULL
respectively	NULL
.	NULL

PD98059	NULL
also	NULL
inhibited	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
ERK2	NULL
activity	NULL
in	NULL
ML-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
PD98059	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
TPA-induced	NULL
JNK1	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
mRNA	NULL
in	NULL
Response	NULL
to	NULL
TPA	NULL
Treatment	NULL
:	NULL
Effect	NULL
of	NULL
PD98059	NULL
.	NULL

Phorbol	NULL
ester-induced	NULL
cell	NULL
differentiation	NULL
is	NULL
mediated	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
AP-1	NULL
complex	NULL
(	NULL
1	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
explored	NULL
the	NULL
expression	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
during	NULL
TPA-induced	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
mRNAs	NULL
in	NULL
ML-1	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
0.3	NULL
ng/m	NULL
!	NULL

TPA	NULL
was	NULL
assessed	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
TPA	NULL
treatment	NULL
of	NULL
ML-1	NULL
cells	NULL
led	NULL
to	NULL
a	NULL
elevation	NULL
of	NULL
c-jun	NULL
mRNA	NULL
,	NULL
which	NULL
reached	NULL
a	NULL
maximum	NULL
by	NULL
6	NULL
h.	NULL
By	NULL
contrast	NULL
,	NULL
c-fos	NULL
mRNA	NULL
was	NULL
rapidly	NULL
induced	NULL
within	NULL
1	NULL
h	NULL
exposure	NULL
to	NULL
TPA	NULL
and	NULL
remained	NULL
relatively	NULL
constant	NULL
for	NULL
at	NULL
least	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Because	NULL
ERK	NULL
and	NULL
JNK	NULL
have	NULL
been	NULL
proposed	NULL
to	NULL
regulate	NULL
AP-1	NULL
function	NULL
(	NULL
9	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
PD98059	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
mRNA	NULL
in	NULL
response	NULL
to	NULL
TPA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
TPA-induced	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
was	NULL
dramatically	NULL
inhibited	NULL
by	NULL
treatment	NULL
with	NULL
PD98059	NULL
,	NULL
whereas	NULL
that	NULL
of	NULL
c-fos	NULL
mRNA	NULL
was	NULL
affected	NULL
minimally	NULL
.	NULL

Effect	NULL
of	NULL
PD98059	NULL
on	NULL
TPA-induced	NULL
ML-1	NULL
Cell	NULL
Differentiation	NULL
.	NULL

Exposure	NULL
to	NULL
TPA	NULL
induces	NULL
macrophage-like	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
(	NULL
36-39	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
contribution	NULL
of	NULL
ERK	NULL
in	NULL
this	NULL
process	NULL
,	NULL
PD98059	NULL
was	NULL
used	NULL
to	NULL
examine	NULL
the	NULL
biological	NULL
consequences	NULL
of	NULL
inhibiting	NULL
the	NULL
MEK/ERK	NULL
signaling	NULL
PD	NULL
TPA	NULL
PD+TPA	NULL
only	NULL
0	NULL
3	NULL
6	NULL
16	NULL
24	NULL
3	NULL
6	NULL
16	NULL
24	NULL
6	NULL
time	NULL
(	NULL
h	NULL
)	NULL
c-jun	NULL
c-fos	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
PD98059	NULL
on	NULL
c-jun	NULL
and	NULL
c-fos	NULL
mRNA	NULL
expression	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
TPA	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
wm	NULL
PD98059	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
an	NULL
18S	NULL
rRNA	NULL
probe	NULL
to	NULL
visualize	NULL
differences	NULL
in	NULL
loading	NULL
and	NULL
transfer	NULL
among	NULL
samples	NULL
.	NULL

Blots	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

pathways	NULL
.	NULL

ML-1	NULL
cells	NULL
treated	NULL
with	NULL
0.3	NULL
ng/m	NULL
!	NULL

TPA	NULL
for	NULL
3	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
in	NULL
culture	NULL
after	NULL
the	NULL
removal	NULL
of	NULL
TPA	NULL
,	NULL
displayed	NULL
morphological	NULL
features	NULL
typical	NULL
of	NULL
mono-cytes/macrophages	NULL
(	NULL
Fig	NULL
.	NULL

6c	NULL
)	NULL
as	NULL
they	NULL
ceased	NULL
to	NULL
proliferate	NULL
and	NULL
were	NULL
enlarged	NULL
,	NULL
with	NULL
a	NULL
higher	NULL
cytoplasmic	NULL
:	NULL
nuclear	NULL
ratio	NULL
than	NULL
that	NULL
of	NULL
undifferentiated	NULL
ML-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
a	NULL
and	NULL
c	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
cells	NULL
treated	NULL
simultaneously	NULL
with	NULL
10	NULL
um	NULL
PD98059	NULL
and	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
continued	NULL
to	NULL
proliferate	NULL
and	NULL
exhibited	NULL
a	NULL
morphology	NULL
resembling	NULL
that	NULL
of	NULL
undifferentiated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
a	NULL
and	NULL
a	NULL
)	NULL
.	NULL

PD98059	NULL
itself	NULL
did	NULL
not	NULL
exert	NULL
any	NULL
detectable	NULL
effect	NULL
on	NULL
either	NULL
cell	NULL
growth	NULL
or	NULL
differentiation	NULL
(	NULL
Fig	NULL
.	NULL

6b	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PD98059	NULL
on	NULL
differentiation	NULL
was	NULL
assessed	NULL
by	NULL
studying	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
monocyte/macrophage-spe-cific	NULL
marker	NULL
a-naphthyl	NULL
acetate	NULL
esterase	NULL
(	NULL
NSE	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
(	NULL
panel	NULL
c	NULL
)	NULL
,	NULL
cells	NULL
differentiated	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
displayed	NULL
positive	NULL
NSE	NULL
staining	NULL
,	NULL
exhibiting	NULL
red-brown	NULL
cyto-plasms	NULL
.	NULL

NSE	NULL
staining	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
0.3	NULL
ng/m	NULL
!	NULL

TPA	NULL
plus	NULL
10	NULL
wm	NULL
PD98059	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
undifferentiated	NULL
ML-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
panels	NULL
a	NULL
and	NULL
d	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
NSE	NULL
activity	NULL
by	NULL
PD98059	NULL
was	NULL
dose	NULL
dependent	NULL
.	NULL

Ninety	NULL
%	NULL
of	NULL
the	NULL
TPA-differentiated	NULL
cells	NULL
were	NULL
NSE-positive	NULL
,	NULL
whereas	NULL
only	NULL
20	NULL
or	NULL
15	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
treated	NULL
with	NULL
TPA	NULL
plus	NULL
10	NULL
or	NULL
20	NULL
um	NULL
PD98059	NULL
were	NULL
NSE	NULL
positive	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

We	NULL
then	NULL
assessed	NULL
the	NULL
effect	NULL
of	NULL
PD98059	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
perform	NULL
phagocytosis	NULL
,	NULL
another	NULL
marker	NULL
of	NULL
macrophage	NULL
differentiation	NULL
.	NULL

Compared	NULL
with	NULL
undifferentiated	NULL
cells	NULL
(	NULL
untreated	NULL
cells	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
panel	NULL
a	NULL
)	NULL
,	NULL
TPA-differentiated	NULL
cells	NULL
were	NULL
able	NULL
to	NULL
effectively	NULL
ingest	NULL
opsonized	NULL
SRBCs	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
(	NULL
panel	NULL
c	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neither	NULL
cells	NULL
treated	NULL
with	NULL
PD98059	NULL
alone	NULL
nor	NULL
cells	NULL
treated	NULL
with	NULL
TPA	NULL
plus	NULL
PD98059	NULL
were	NULL
phagocytic	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
SRBCs	NULL
outside	NULL
the	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
panels	NULL
b	NULL
and	NULL
d	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
,	NULL
both	NULL
the	NULL
percentage	NULL
of	NULL
phagocytic	NULL
cells	NULL
and	NULL
the	NULL
number	NULL
of	NULL
SRBCs	NULL
ingested	NULL
per	NULL
cell	NULL
were	NULL
decreased	NULL
by	NULL
treatment	NULL
with	NULL
PD98059	NULL
.	NULL

Superoxide	NULL
produced	NULL
by	NULL
NADPH	NULL
oxidase	NULL
is	NULL
another	NULL
marker	NULL
used	NULL
frequently	NULL
to	NULL
monitor	NULL
granulocytic	NULL
and	NULL
monocytic	NULL
differ	NULL
309	NULL
310	NULL
-	NULL
Block	NULL
by	NULL
PD98059	NULL
of	NULL
Mononuclear	NULL
Cell	NULL
Differentiation	NULL
entiation	NULL
because	NULL
the	NULL
undifferentiated	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
NADPH	NULL
oxidase	NULL
activity	NULL
(	NULL
43-45	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
ability	NULL
of	NULL
ML-1	NULL
cells	NULL
to	NULL
produce	NULL
superoxide	NULL
via	NULL
NADPH	NULL
oxidase	NULL
both	NULL
at	NULL
a	NULL
basal	NULL
level	NULL
(	NULL
resting	NULL
state	NULL
)	NULL
and	NULL
at	NULL
a	NULL
state	NULL
stimulated	NULL
by	NULL
exposure	NULL
the	NULL
cells	NULL
to	NULL
30	NULL
ng/m	NULL
!	NULL

TPA	NULL
in	NULL
the	NULL
assay	NULL
reactions	NULL
.	NULL

Undifferentiated	NULL
ML-1	NULL
cells	NULL
showed	NULL
little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
superoxide	NULL
production	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
whereas	NULL
cells	NULL
differentiated	NULL
with	NULL
TPA	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PD98059	NULL
exhibited	NULL
a	NULL
basal	NULL
level	NULL
of	NULL
6.5	NULL
nmol	NULL
superoxide/h/10©	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

94	NULL
)	NULL
and	NULL
a	NULL
stimulated	NULL
level	NULL
of	NULL
70	NULL
nmol	NULL
superoxide/h/10©	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

In	NULL
cells	NULL
treated	NULL
with	NULL
0.3	NULL
ng/m	NULL
!	NULL

TPA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
doses	NULL
of	NULL
PD98059	NULL
,	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
superoxide	NULL
production	NULL
decreased	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

94	NULL
)	NULL
.	NULL

PD98059	NULL
,	NULL
at	NULL
10	NULL
um	NULL
concentration	NULL
,	NULL
decreased	NULL
the	NULL
superoxide	NULL
production	NULL
down	NULL
to	NULL
that	NULL
of	NULL
undifferentiated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

94	NULL
)	NULL
.	NULL

PD98059	NULL
also	NULL
caused	NULL
a	NULL
dose-dependent	NULL
reduction	NULL
in	NULL
superoxide	NULL
production	NULL
by	NULL
the	NULL
stimulated	NULL
NADPH	NULL
oxidase	NULL
in	NULL
cells	NULL
differentiated	NULL
with	NULL
TPA	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
that	NULL
at	NULL
2.5	NULL
um	NULL
concentration	NULL
of	NULL
PD98059	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

Of	NULL
interest	NULL
was	NULL
the	NULL
finding	NULL
that	NULL
cells	NULL
differentiated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TPA	NULL
plus	NULL
2.5	NULL
um	NULL
PD98059	NULL
exhibited	NULL
a	NULL
greater	NULL
superoxide	NULL
production	NULL
than	NULL
cells	NULL
terminally	NULL
differentiated	NULL
with	NULL
TPA	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PD98059	NULL
.	NULL

The	NULL
cells	NULL
treated	NULL
with	NULL
TPA	NULL
plus	NULL
2.5	NULL
um	NULL
PD98059	NULL
continued	NULL
to	NULL
proliferate	NULL
and	NULL
,	NULL
morphologically	NULL
,	NULL
they	NULL
appeared	NULL
to	NULL
be	NULL
less	NULL
mature	NULL
than	NULL
the	NULL
TPA-differentiated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Other	NULL
investigators	NULL
have	NULL
previously	NULL
observed	NULL
that	NULL
less	NULL
differentiated	NULL
monocytes	NULL
have	NULL
a	NULL
higher	NULL
ability	NULL
to	NULL
generate	NULL
superoxide	NULL
via	NULL
NADPH	NULL
oxidase	NULL
than	NULL
do	NULL
mature	NULL
macrophages	NULL
(	NULL
36	NULL
,	NULL
46	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
effect	NULL
of	NULL
PD98059	NULL
on	NULL
mitochondrial	NULL
maturation	NULL
during	NULL
TPA-induced	NULL
ML-1	NULL
cell	NULL
differentiation	NULL
.	NULL

Fully	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
PD98059	NULL
on	NULL
TPA-induced	NULL
morphological	NULL
characteristics	NULL
of	NULL
ML-1	NULL
cells	NULL
.	NULL

a	NULL
,	NULL
undifferentiated	NULL
ML-1	NULL
cells	NULL
;	NULL
b	NULL
,	NULL
cells	NULL
treated	NULL
with	NULL
10	NULL
wm	NULL
PD98059	NULL
alone	NULL
;	NULL
c	NULL
,	NULL
cells	NULL
treated	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
for	NULL
3	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
in	NULL
culture	NULL
without	NULL
TPA	NULL
;	NULL
d	NULL
,	NULL
cells	NULL
differentiated	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
wm	NULL
PD98059	NULL
for	NULL
3	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TPA	NULL
and	NULL
PD98059	NULL
.	NULL

x200	NULL
.	NULL

differentiated	NULL
macrophages	NULL
exhibit	NULL
mitochondrial	NULL
respiration	NULL
,	NULL
whereas	NULL
undifferentiated	NULL
myeloid	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
gran-ulocytes	NULL
lack	NULL
appreciable	NULL
levels	NULL
of	NULL
mitochondrial	NULL
respiration	NULL
(	NULL
39	NULL
,	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

As	NULL
ML-1	NULL
cells	NULL
differentiate	NULL
into	NULL
macrophages	NULL
,	NULL
they	NULL
exhibit	NULL
increases	NULL
in	NULL
mitochondrial-dependent	NULL
oxygen	NULL
consumption	NULL
and	NULL
ATP	NULL
production	NULL
,	NULL
which	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
the	NULL
mitochondrial	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
chloramphenicol	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Superoxide	NULL
produced	NULL
as	NULL
a	NULL
by-product	NULL
of	NULL
mitochondrial	NULL
respiration	NULL
can	NULL
be	NULL
measured	NULL
by	NULL
using	NULL
a	NULL
chemilumigenic	NULL
probe	NULL
,	NULL
lucigenin	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
sensitive	NULL
biomarker	NULL
of	NULL
mitochondrial	NULL
maturation	NULL
during	NULL
ML-1	NULL
cell	NULL
differentiation	NULL
(	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
mitochondrial	NULL
superoxide	NULL
production	NULL
in	NULL
the	NULL
TPA-differentiated	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
PD98059	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
treatment	NULL
of	NULL
PD98059	NULL
abolished	NULL
TPA-induced	NULL
mononuclear	NULL
cell	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
as	NULL
assessed	NULL
by	NULL
cell	NULL
morphology	NULL
,	NULL
NSE	NULL
activity	NULL
,	NULL
phagocytic	NULL
ability	NULL
,	NULL
NADPH	NULL
oxidase	NULL
activity	NULL
,	NULL
and	NULL
mitochondrial	NULL
respiration	NULL
.	NULL

These	NULL
findings	NULL
strongly	NULL
indicate	NULL
a	NULL
role	NULL
for	NULL
ERK	NULL
in	NULL
mononuclear	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
.	NULL

Discussion	NULL
The	NULL
TPA-induced	NULL
mononuclear	NULL
differentiation	NULL
of	NULL
human	NULL
my-elogenous	NULL
leukemia	NULL
cells	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
mediated	NULL
through	NULL
PKC	NULL
(	NULL
52-55	NULL
)	NULL
.	NULL

The	NULL
biological	NULL
activity	NULL
of	NULL
TPA	NULL
is	NULL
initiated	NULL
by	NULL
its	NULL
binding	NULL
to	NULL
PKC	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
translocation	NULL
of	NULL
PKC	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
cellular	NULL
membranes	NULL
,	NULL
resulting	NULL
in	NULL
its	NULL
activation	NULL
(	NULL
56	NULL
,	NULL
57	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
report	NULL
has	NULL
shown	NULL
that	NULL
TPA-induced	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
a	NULL
PKC-specific	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
PD98059	NULL
on	NULL
ML-1	NULL
cell	NULL
NSE	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
representative	NULL
microscopic	NULL
appearance	NULL
of	NULL
the	NULL
cells	NULL
stained	NULL
for	NULL
NSE	NULL
activity	NULL
.	NULL

a	NULL
,	NULL
undifferentiated	NULL
ML-1	NULL
cells	NULL
;	NULL
b	NULL
,	NULL
cells	NULL
treated	NULL
with	NULL
10	NULL
um	NULL
PD98059	NULL
alone	NULL
;	NULL
c	NULL
,	NULL
cells	NULL
treated	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
for	NULL
3	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
in	NULL
culture	NULL
without	NULL
TPA	NULL
;	NULL
d	NULL
,	NULL
cells	NULL
differentiated	NULL
with	NULL
0.3	NULL
ng/m|	NULL
TPA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
un	NULL
PD98059	NULL
for	NULL
3	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
in	NULL
culture	NULL
without	NULL
TPA	NULL
and	NULL
PD98059	NULL
.	NULL

B	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
and	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
PD98059	NULL
for	NULL
3	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
in	NULL
culture	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
either	NULL
compound	NULL
.	NULL

Undiff	NULL
.	NULL

,	NULL
undifferentiated	NULL
ML-1	NULL
cells	NULL
.	NULL

A	NULL
minimum	NULL
of	NULL
200	NULL
cells/slide	NULL
were	NULL
counted	NULL
,	NULL
and	NULL
percentages	NULL
of	NULL
brown-stained	NULL
positive	NULL
cells	NULL
were	NULL
cal-culated	NULL
.	NULL

Values	NULL
presented	NULL
are	NULL
means	NULL
;	NULL
bars	NULL
,	NULL
SE	NULL
;	NULL
n	NULL
=	NULL
3.	NULL
a	NULL
#	NULL
!	NULL

&	NULL
..	NULL
»	NULL
*	NULL
%	NULL
&	NULL
7	NULL
&	NULL
»	NULL
&	NULL
.	NULL

4	NULL
.	NULL

y	NULL
Y	NULL
.g	NULL
®	NULL
~-	NULL
F	NULL
1.	NULL
imi	NULL
»	NULL
d	NULL
#	NULL
%	NULL
ﬁ	NULL
‘	NULL
«	NULL
1,4	NULL
Es	NULL
P	NULL
£	NULL
80	NULL
60	NULL
40	NULL
20	NULL
0	NULL
+	NULL
u	NULL
Percent	NULL
Cells	NULL
NSE-Positive	NULL
*	NULL
inhibitor	NULL
,	NULL
suggesting	NULL
that	NULL
PKC	NULL
is	NULL
essential	NULL
for	NULL
TPA-induced	NULL
HL-60	NULL
cell	NULL
differentiation	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Much	NULL
evidence	NULL
supports	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
ERK	NULL
cascade	NULL
as	NULL
an	NULL
important	NULL
signaling	NULL
pathway	NULL
in	NULL
cell	NULL
differentiation	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
neuronal	NULL
differentiation	NULL
of	NULL
PC12	NULL
cells	NULL
is	NULL
one	NULL
of	NULL
the	NULL
most	NULL
extensively	NULL
studied	NULL
systems	NULL
.	NULL

Constitutively	NULL
active	NULL
mutants	NULL
of	NULL
MEK	NULL
and	NULL
active	NULL
forms	NULL
of	NULL
each	NULL
component	NULL
of	NULL
the	NULL
ERK	NULL
cascade	NULL
have	NULL
been	NULL
used	NULL
to	NULL
demonstrate	NULL
that	NULL
persistent	NULL
activation	NULL
of	NULL
MEK	NULL
or	NULL
ERK	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
differentiation	NULL
of	NULL
PC12	NULL
cells	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
expression	NULL
of	NULL
dominant-negative	NULL
MEK	NULL
mutants	NULL
that	NULL
prevent	NULL
ERK	NULL
activation	NULL
or	NULL
expression	NULL
of	NULL
a	NULL
phosphatase	NULL
that	NULL
inactivates	NULL
ERK	NULL
abolish	NULL
the	NULL
differentiation-inducing	NULL
effect	NULL
of	NULL
MEK	NULL
kinase	NULL
and	NULL
MEK	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
nerve	NULL
growth	NULL
factor-induced	NULL
neurite	NULL
formation	NULL
of	NULL
PC12	NULL
cells	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
specific	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
,	NULL
providing	NULL
additional	NULL
evidence	NULL
that	NULL
the	NULL
MEK/ERK	NULL
pathway	NULL
is	NULL
necessary	NULL
for	NULL
PC12	NULL
cell	NULL
differentiation	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
essential	NULL
role	NULL
of	NULL
ERK	NULL
cascade	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
other	NULL
cell	NULL
types	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
.	NULL

During	NULL
T-cell	NULL
maturation	NULL
,	NULL
the	NULL
positive	NULL
selection	NULL
of	NULL
thymocyte	NULL
development	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
blocked	NULL
when	NULL
a	NULL
catalytically	NULL
inactive	NULL
form	NULL
of	NULL
Undiff	NULL
.	NULL

0	NULL
2.5	NULL
5	NULL
10	NULL
20	NULL
PD	NULL
(	NULL
uM	NULL
)	NULL
TPA-Differentiated	NULL
MEK1	NULL
was	NULL
expressed	NULL
in	NULL
immature	NULL
cells	NULL
(	NULL
59	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
Whalen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
demonstrated	NULL
that	NULL
ERK	NULL
was	NULL
activated	NULL
during	NULL
the	NULL
TPA-induced	NULL
megakaryocytic	NULL
differentiation	NULL
of	NULL
K562	NULL
cells	NULL
.	NULL

Using	NULL
constitutively	NULL
active	NULL
MEK	NULL
mutants	NULL
and	NULL
PD98059	NULL
,	NULL
they	NULL
showed	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
ERK	NULL
and	NULL
MEK	NULL
was	NULL
sufficient	NULL
and	NULL
necessary	NULL
for	NULL
megakaryocytic	NULL
differentiation	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
other	NULL
stud-ies	NULL
,	NULL
TPA-induced	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
into	NULL
monocytes/	NULL
macrophages	NULL
was	NULL
also	NULL
accompanied	NULL
by	NULL
activation	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Raf	NULL
and	NULL
ERK	NULL
were	NULL
reportedly	NULL
activated	NULL
during	NULL
mononuclear	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
induced	NULL
by	NULL
TPA	NULL
(	NULL
61	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
observations	NULL
reported	NULL
here	NULL
that	NULL
ERK1	NULL
,	NULL
ERK2	NULL
,	NULL
and	NULL
JNK1	NULL
were	NULL
activated	NULL
during	NULL
the	NULL
TPA-induced	NULL
mononuclear	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
by	NULL
Meighan-Mantha	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
showed	NULL
that	NULL
,	NULL
during	NULL
TPA-induced	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
,	NULL
total	NULL
ERK	NULL
activity	NULL
was	NULL
dramatically	NULL
reduced	NULL
,	NULL
an	NULL
effect	NULL
that	NULL
was	NULL
attributed	NULL
primarily	NULL
to	NULL
the	NULL
rapid	NULL
deactivation	NULL
of	NULL
ERK1	NULL
.	NULL

The	NULL
discrepancies	NULL
between	NULL
this	NULL
study	NULL
and	NULL
ours	NULL
may	NULL
perhaps	NULL
reflect	NULL
differences	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
used	NULL
.	NULL

However	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
findings	NULL
of	NULL
Meighan-Mantha	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
33	NULL
)	NULL
,	NULL
we	NULL
also	NULL
observed	NULL
that	NULL
ERK1	NULL
and	NULL
ERK2	NULL
activities	NULL
were	NULL
reduced	NULL
to	NULL
below	NULL
basal	NULL
levels	NULL
after	NULL
a	NULL
311	NULL
312	NULL
-	NULL
Block	NULL
by	NULL
PD98059	NULL
of	NULL
Mononuclear	NULL
Cell	NULL
Differentiation	NULL
s	NULL
a	NULL
s	NULL
100	NULL
E	NULL
14	NULL
5	NULL
so	NULL
3	NULL
12	NULL
a	NULL
#	NULL
10	NULL
&	NULL
60	NULL
B	NULL
a	NULL
A	NULL
8	NULL
=	NULL
wn	NULL
3	NULL
40	NULL
E	NULL
6	NULL
5	NULL
20	NULL
®	NULL
5	NULL
E	NULL
o	NULL
2	NULL
3	NULL
*	NULL
o	NULL
é	NULL
0	NULL
Undiff	NULL
_	NULL
TPA	NULL
_	NULL
TPA+	NULL
Z	NULL
Undiff	NULL
.	NULL

PD	NULL
rapid	NULL
early	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
at	NULL
present	NULL
whether	NULL
this	NULL
reduction	NULL
in	NULL
ERK1	NULL
and	NULL
ERK2	NULL
activity	NULL
at	NULL
later	NULL
times	NULL
plays	NULL
any	NULL
role	NULL
in	NULL
mononuclear	NULL
cell	NULL
differentiation	NULL
.	NULL

The	NULL
biological	NULL
effects	NULL
of	NULL
TPA	NULL
are	NULL
mediated	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
the	NULL
generation	NULL
of	NULL
active	NULL
AP-1	NULL
complexes	NULL
,	NULL
which	NULL
are	NULL
predominantly	NULL
composed	NULL
of	NULL
heterodimers	NULL
of	NULL
c-Jun/c-Fos	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
c-Jun/c-Fos	NULL
AP-1	NULL
complexes	NULL
is	NULL
often	NULL
mediated	NULL
by	NULL
phosphorylation	NULL
of	NULL
the	NULL
protein	NULL
components	NULL
,	NULL
thus	NULL
resulting	NULL
in	NULL
enhanced	NULL
AP-1	NULL
function	NULL
(	NULL
8-11	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
presented	NULL
here	NULL
indicate	NULL
an	NULL
additional	NULL
level	NULL
of	NULL
regulation	NULL
wherein	NULL
ERK	NULL
potentially	NULL
regulates	NULL
AP-1	NULL
activity	NULL
by	NULL
directly	NULL
altering	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
.	NULL

The	NULL
experiments	NULL
using	NULL
PD98059	NULL
indicate	NULL
that	NULL
ERK-regulated	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
by	NULL
TPA	NULL
is	NULL
specific	NULL
,	NULL
because	NULL
addition	NULL
of	NULL
PD98059	NULL
completely	NULL
suppresses	NULL
TPA-induced	NULL
c-jun	NULL
mRNA	NULL
but	NULL
only	NULL
minimally	NULL
affects	NULL
the	NULL
TPA-mediated	NULL
induction	NULL
of	NULL
c-fos	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
during	NULL
TPA-induced	NULL
differentiation	NULL
,	NULL
AP-1	NULL
activity	NULL
may	NULL
be	NULL
influenced	NULL
by	NULL
ERK	NULL
(	NULL
and/or	NULL
JNK	NULL
)	NULL
-mediated	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
,	NULL
but	NULL
additionally	NULL
,	NULL
ERK	NULL
also	NULL
tightly	NULL
regulates	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
.	NULL

Whether	NULL
c-jun	NULL
expression	NULL
directly	NULL
influences	NULL
the	NULL
differentiation	NULL
phenotype	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
provided	NULL
evidence	NULL
supporting	NULL
the	NULL
requirement	NULL
for	NULL
MEK/ERK	NULL
activation	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
dif-	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
PD98059	NULL
on	NULL
phagocytosis	NULL
of	NULL
SRBCs	NULL
by	NULL
ML-1	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
representative	NULL
photomicrographs	NULL
of	NULL
ML-1	NULL
cells	NULL
analyzed	NULL
for	NULL
phagocytic	NULL
capability	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

a	NULL
,	NULL
undifferentiated	NULL
ML-1	NULL
cells	NULL
;	NULL
b	NULL
,	NULL
cells	NULL
treated	NULL
with	NULL
10	NULL
um	NULL
PD98059	NULL
alone	NULL
;	NULL
c	NULL
,	NULL
cells	NULL
differentiated	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
for	NULL
3	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
in	NULL
culture	NULL
without	NULL
TPA	NULL
;	NULL
d	NULL
,	NULL
cells	NULL
differentiated	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
um	NULL
PD98059	NULL
for	NULL
3	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TPA	NULL
and	NULL
PD98059	NULL
.	NULL

x200	NULL
.	NULL

B	NULL
,	NULL
percent	NULL
cells	NULL
phagocytic	NULL
.	NULL

C	NULL
,	NULL
number	NULL
of	NULL
SRBCs	NULL
ingested	NULL
per	NULL
ML-1	NULL
cell	NULL
.	NULL

Values	NULL
presented	NULL
are	NULL
means	NULL
;	NULL
bars	NULL
,	NULL
SE	NULL
;	NULL
n	NULL
=	NULL
3	NULL
.	NULL

TPA	NULL
+	NULL
PD	NULL
ferentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
by	NULL
TPA	NULL
.	NULL

The	NULL
specific	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
blocked	NULL
the	NULL
activation	NULL
of	NULL
ERK	NULL
subfamily	NULL
of	NULL
MAPK	NULL
,	NULL
expression	NULL
of	NULL
TPA-induced	NULL
c-jun	NULL
mRNA	NULL
,	NULL
and	NULL
mononuclear	NULL
differentiation	NULL
of	NULL
ML-1	NULL
cells	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
a	NULL
spectrum	NULL
of	NULL
parameters	NULL
:	NULL
cellular	NULL
morphology	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
NSE	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
phagocytic	NULL
capability	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
NADPH	NULL
oxidase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
,	NULL
and	NULL
mitochondrial	NULL
maturation	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

Whether	NULL
MEK/	NULL
ERK	NULL
activation	NULL
is	NULL
sufficient	NULL
for	NULL
differentiation	NULL
is	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

This	NULL
study	NULL
not	NULL
only	NULL
provides	NULL
insight	NULL
into	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
underlie	NULL
the	NULL
process	NULL
of	NULL
macrophage	NULL
differentiation	NULL
,	NULL
but	NULL
it	NULL
also	NULL
supports	NULL
the	NULL
concept	NULL
that	NULL
the	NULL
MEK/ERK	NULL
signaling	NULL
pathway	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cell	NULL
types	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Chemicals	NULL
and	NULL
Materials	NULL
.	NULL

RPMI-1640	NULL
,	NULL
penicillin	NULL
,	NULL
streptomycin	NULL
,	NULL
and	NULL
Dulbecco	NULL
's	NULL
PBS	NULL
were	NULL
purchased	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
,	NULL
(	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

FBS	NULL
and	NULL
all	NULL
other	NULL
chemicals	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Sheep	NULL
blood	NULL
was	NULL
purchased	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Cockeysville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

IgG	NULL
antibody	NULL
against	NULL
sheep	NULL
erythrocytes	NULL
was	NULL
purchased	NULL
from	NULL
Diamedix	NULL
(	NULL
Miami	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
.	NULL

The	NULL
myeloblastic	NULL
leukemic	NULL
cell	NULL
line	NULL
ML-1	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Ruth	NULL
Craig	NULL
(	NULL
Department	NULL
of	NULL
Pharmacology	NULL
and	NULL
Toxicology	NULL
,	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
,	NULL
Hanover	NULL
,	NULL
NH	NULL
)	NULL
.	NULL

ML-1	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
A.	NULL
Basal	NULL
Level	NULL
9	NULL
s	NULL
|	NULL
7	NULL
6	NULL
4	NULL
5	NULL
|	NULL
F	NULL
3	NULL
|	NULL
2	NULL
J	NULL
Superoxide	NULL
Production	NULL
(	NULL
anI/hr/IO6	NULL
cells	NULL
)	NULL
0	NULL
2.5	NULL
5	NULL
10	NULL
20	NULL
PD	NULL
(	NULL
uM	NULL
)	NULL
B	NULL
.	NULL

Stimulated	NULL
Level	NULL
Superoxide	NULL
Production	NULL
(	NULL
nmo¥/hr/10°	NULL
cells	NULL
)	NULL
s	NULL
0	NULL
2.5	NULL
5	NULL
10	NULL
20	NULL
PD	NULL
(	NULL
uM	NULL
)	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
PD98059	NULL
on	NULL
NADPH	NULL
oxidase	NULL
activity	NULL
in	NULL
TPA-differentiated	NULL
ML-1	NULL
cells	NULL
.	NULL

ML-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
and	NULL
indicated	NULL
doses	NULL
of	NULL
PD98059	NULL
for	NULL
3	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
3	NULL
days	NULL
in	NULL
culture	NULL
after	NULL
the	NULL
removal	NULL
of	NULL
both	NULL
TPA	NULL
and	NULL
PD98059	NULL
.	NULL

A	NULL
,	NULL
basal	NULL
level	NULL
of	NULL
superoxide	NULL
produced	NULL
by	NULL
NADPH	NULL
oxidase	NULL
at	NULL
a	NULL
resting	NULL
state	NULL
.	NULL

B	NULL
,	NULL
superoxide	NULL
produced	NULL
by	NULL
NADPH	NULL
oxidase	NULL
at	NULL
a	NULL
stimulated	NULL
state	NULL
.	NULL

Values	NULL
presented	NULL
are	NULL
means	NULL
;	NULL
bars	NULL
,	NULL
SE	NULL
;	NULL
n	NULL
=	NULL
3	NULL
.	NULL

RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
7.5	NULL
%	NULL
heat-inactivated	NULL
FBS	NULL
.	NULL

ML-1	NULL
cells	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

For	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
cells	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
,	NULL
they	NULL
were	NULL
seeded	NULL
in	NULL
FBS-coated	NULL
flasks	NULL
at	NULL
a	NULL
density	NULL
of	NULL
3	NULL
x	NULL
10°	NULL
cells/ml	NULL
(	NULL
37	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Differentiation	NULL
was	NULL
induced	NULL
by	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
(	NULL
dissolved	NULL
in	NULL
DMSO	NULL
;	NULL
final	NULL
concentration	NULL
in	NULL
medium	NULL
,	NULL
0.03	NULL
%	NULL
)	NULL
for	NULL
3	NULL
days	NULL
,	NULL
whereupon	NULL
TPA-containing	NULL
medium	NULL
was	NULL
then	NULL
removed	NULL
and	NULL
replaced	NULL
with	NULL
fresh	NULL
medium	NULL
lacking	NULL
TPA	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
.	NULL

In	NULL
experiments	NULL
using	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
(	NULL
Calbiochem	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
simultaneously	NULL
treated	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
,	NULL
and	NULL
various	NULL
concentrations	NULL
of	NULL
PD98059	NULL
(	NULL
dissolved	NULL
in	NULL
DMSO	NULL
;	NULL
final	NULL
concentration	NULL
in	NULL
medium	NULL
,	NULL
0.03	NULL
%	NULL
)	NULL
for	NULL
3	NULL
days	NULL
.	NULL

Medium	NULL
was	NULL
then	NULL
removed	NULL
and	NULL
replaced	NULL
with	NULL
fresh	NULL
medium	NULL
without	NULL
either	NULL
TPA	NULL
or	NULL
PD98059	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
3	NULL
days	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
after	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
from	NULL
the	NULL
flasks	NULL
and	NULL
resuspended	NULL
in	NULL
complete	NULL
Dulbecco	NULL
's	NULL
PBS	NULL
with	NULL
0.01	NULL
%	NULL
MgCl	NULL
»	NULL
,	NULL
0.01	NULL
%	NULL
CaCl	NULL
»	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
glucose	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

For	NULL
morphological	NULL
char-acterization	NULL
,	NULL
photomicrographs	NULL
were	NULL
taken	NULL
using	NULL
an	NULL
inverted	NULL
phase	NULL
contrast	NULL
microscope	NULL
while	NULL
the	NULL
cells	NULL
were	NULL
in	NULL
the	NULL
tissue	NULL
culture	NULL
flasks	NULL
.	NULL

Mitochondrial-dependent	NULL
LDCL	NULL
.	NULL

LDCL	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
the	NULL
production	NULL
of	NULL
superoxide	NULL
anion	NULL
from	NULL
mitochondrial	NULL
respiration	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
resuspended	NULL
in	NULL
Dulbecco	NULL
's	NULL
PBS	NULL
.	NULL

One	NULL
million	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
2.5	NULL
ml	NULL
.	NULL

The	NULL
final	NULL
concentration	NULL
of	NULL
lucigenin	NULL
(	NULL
bis-N-methylacridinium	NULL
nitrate	NULL
;	NULL
Aldrich	NULL
,	NULL
Milwaukee	NULL
,	NULL
WI	NULL
)	NULL
was	NULL
1	NULL
m	NULL
,	NULL
a	NULL
concentration	NULL
at	NULL
which	NULL
lucigenin	NULL
does	NULL
not	NULL
redox-cycle	NULL
(	NULL
51	NULL
)	NULL
.	NULL

LDCL	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
Berthold	NULL
Biolumat	NULL
LB9505	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h.	NULL
Data	NULL
from	NULL
LDCL	NULL
experiments	NULL
is	NULL
expressed	NULL
as	NULL
integrated	NULL
chemiluminescence	NULL
.	NULL

Superoxide	NULL
Anion	NULL
Production	NULL
by	NULL
NADPH	NULL
Oxidase	NULL
.	NULL

The	NULL
superoxide	NULL
dismutase-inhibitable	NULL
reduction	NULL
of	NULL
cytochrome	NULL
c	NULL
was	NULL
used	NULL
to	NULL
quantitate	NULL
100	NULL
Integrated	NULL
Lucigenin-Derived	NULL
CL	NULL
(	NULL
cpmX10	NULL
)	NULL
Undiff	NULL
-	NULL
0	NULL
__	NULL
1	NULL
__	NULL
25	NULL
__	NULL
5	NULL
__	NULL
10	NULL
)	NULL
___20	NULL
+PD	NULL
(	NULL
uM	NULL
)	NULL
TPA-Differentiated	NULL
Fig	NULL
.	NULL

10	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
PD98059	NULL
on	NULL
mitochondrial	NULL
respiration	NULL
in	NULL
TPA-differentiated	NULL
cells	NULL
.	NULL

ML-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
0.3	NULL
ng/ml	NULL
TPA	NULL
and	NULL
indicated	NULL
doses	NULL
of	NULL
PD98059	NULL
for	NULL
3	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
3	NULL
days	NULL
in	NULL
culture	NULL
after	NULL
the	NULL
removal	NULL
of	NULL
both	NULL
.	NULL

Superoxide	NULL
production	NULL
via	NULL
mitochondrial	NULL
respiration	NULL
was	NULL
assessed	NULL
by	NULL
LDCL	NULL
.	NULL

Values	NULL
presented	NULL
are	NULL
means	NULL
;	NULL
bars	NULL
,	NULL
SE	NULL
;	NULL
n	NULL
=	NULL
3.	NULL
production	NULL
of	NULL
superoxide	NULL
anion	NULL
generated	NULL
by	NULL
NADPH	NULL
oxidase	NULL
.	NULL

This	NULL
protocol	NULL
was	NULL
modified	NULL
from	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Kensler	NULL
and	NULL
Trush	NULL
(	NULL
62	NULL
)	NULL
.	NULL

The	NULL
reactions	NULL
contained	NULL
10°	NULL
cells	NULL
and	NULL
3	NULL
mg	NULL
cytochrome	NULL
c	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
2	NULL
ml	NULL
,	NULL
either	NULL
containing	NULL
or	NULL
lacking	NULL
0.15	NULL
mg	NULL
of	NULL
superoxide	NULL
dismutase	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
reactions	NULL
were	NULL
terminated	NULL
by	NULL
placing	NULL
tubes	NULL
at	NULL
4°C	NULL
,	NULL
followed	NULL
by	NULL
centrifugation	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
assayed	NULL
spectrophotometrically	NULL
at	NULL
550	NULL
nm	NULL
.	NULL

Absorbance	NULL
values	NULL
were	NULL
converted	NULL
to	NULL
nmol	NULL
superoxide	NULL
production/h/10©	NULL
cells	NULL
.	NULL

The	NULL
values	NULL
were	NULL
corrected	NULL
for	NULL
the	NULL
portion	NULL
of	NULL
nonsuperoxide-dependent	NULL
reduction	NULL
of	NULL
cytochrome	NULL
c	NULL
,	NULL
which	NULL
was	NULL
not	NULL
inhibitable	NULL
by	NULL
superoxide	NULL
dismutase	NULL
.	NULL

For	NULL
measurement	NULL
of	NULL
NADPH	NULL
oxidase	NULL
activity	NULL
at	NULL
a	NULL
stimulated	NULL
state	NULL
,	NULL
TPA	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

was	NULL
used	NULL
in	NULL
the	NULL
assay	NULL
reactions	NULL
.	NULL

NSE	NULL
Activity	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
nonspecific	NULL
esterase	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
a-naphthy	NULL
!	NULL

acetate	NULL
as	NULL
a	NULL
substrate	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Ennist	NULL
and	NULL
Jones	NULL
(	NULL
63	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
resuspended	NULL
in	NULL
complete	NULL
PBS	NULL
at	NULL
10°	NULL
cells/ml	NULL
.	NULL

The	NULL
working	NULL
buffer-substrate	NULL
solution	NULL
,	NULL
made	NULL
immediately	NULL
before	NULL
use	NULL
,	NULL
consisted	NULL
of	NULL
10	NULL
ml	NULL
of	NULL
0.1	NULL
m	NULL
phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
7.3	NULL
)	NULL
,	NULL
0.25	NULL
ml	NULL
1	NULL
%	NULL
a-naphthyl	NULL
acetate	NULL
,	NULL
and	NULL
0.8	NULL
ml	NULL
of	NULL
freshly	NULL
made	NULL
hexazonium	NULL
pararosaniline	NULL
.	NULL

One	NULL
ml	NULL
of	NULL
buffer-substrate	NULL
solution	NULL
was	NULL
added	NULL
to	NULL
1	NULL
ml	NULL
of	NULL
cell	NULL
suspension	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
300	NULL
cells	NULL
were	NULL
counted	NULL
;	NULL
cells	NULL
displaying	NULL
intense	NULL
red-brown	NULL
azo	NULL
dye	NULL
in	NULL
the	NULL
cytoplasm	NULL
were	NULL
scored	NULL
as	NULL
NSE	NULL
positive	NULL
.	NULL

Fc	NULL
Membrane	NULL
Receptor-mediated	NULL
Phagocytosis	NULL
.	NULL

A	NULL
0.2-ml	NULL
aliquot	NULL
of	NULL
a	NULL
0.25	NULL
%	NULL
suspension	NULL
of	NULL
opsonized	NULL
SRBCs	NULL
in	NULL
RPMI	NULL
1640	NULL
was	NULL
added	NULL
to	NULL
0.5	NULL
x	NULL
10°	NULL
cells	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
0.7	NULL
ml	NULL
.	NULL

Then	NULL
the	NULL
Fo	NULL
membrane	NULL
receptor-mediated	NULL
phagocytic	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
humidified	NULL
incubator	NULL
filled	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
at	NULL
37°C	NULL
for	NULL
30-45	NULL
min	NULL
.	NULL

Noningested	NULL
RBCs	NULL
were	NULL
hypotonically	NULL
lysed	NULL
for	NULL
30	NULL
s	NULL
by	NULL
adding	NULL
distilled	NULL
water	NULL
.	NULL

The	NULL
hypotonic	NULL
condition	NULL
was	NULL
restored	NULL
to	NULL
isotonicity	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
1.8	NULL
%	NULL
NaCl	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
PBS	NULL
.	NULL

Slides	NULL
were	NULL
prepared	NULL
by	NULL
using	NULL
a	NULL
cytospin	NULL
(	NULL
Shandon	NULL
)	NULL
at	NULL
1000	NULL
rom	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
air-dried	NULL
,	NULL
fixed	NULL
with	NULL
methanol	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
Wright-Giemsa	NULL
(	NULL
Fisher	NULL
)	NULL
.	NULL

The	NULL
stained	NULL
cells	NULL
were	NULL
visualized	NULL
microscopically	NULL
at	NULL
a	NULL
magnification	NULL
of	NULL
X400	NULL
to	NULL
quantify	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
containing	NULL
SRBCs	NULL
and	NULL
the	NULL
number	NULL
of	NULL
SRBCs	NULL
ingested	NULL
per	NULL
actively	NULL
phagocytic	NULL
cells	NULL
.	NULL

At	NULL
least	NULL
100	NULL
cells/slide	NULL
were	NULL
counted	NULL
.	NULL

Northern	NULL
Blotting	NULL
Analysis	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
using	NULL
the	NULL
procedure	NULL
initially	NULL
described	NULL
by	NULL
Chomczynski	NULL
and	NULL
Sacchi	NULL
(	NULL
64	NULL
)	NULL
and	NULL
Qiagen	NULL
RNeasy	NULL
Mini	NULL
kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Inc.	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
electrophoresed	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
Nytran	NULL
membrane	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
(	NULL
ICN	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
a	NULL
random	NULL
primer	NULL
labeling	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
cDNA	NULL
probe	NULL
overnight	NULL
at	NULL
42°C	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
6x	NULL
SSC	NULL
,	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5x	NULL
Denhardt	NULL
's	NULL
reagent	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
SDS	NULL
.	NULL

After	NULL
the	NULL
membranes	NULL
were	NULL
washed	NULL
with	NULL
1	NULL
%	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
they	NULL
313	NULL
314	NULL
Block	NULL
by	NULL
PD98059	NULL
of	NULL
Mononuclear	NULL
Cell	NULL
Differentiation	NULL
were	NULL
subjected	NULL
to	NULL
autoradiography	NULL
at	NULL
-70°C	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
and/or	NULL
quantitated	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

An	NULL
oligomer	NULL
complementary	NULL
to	NULL
18	NULL
$	NULL
rRNA	NULL
was	NULL
end-labeled	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
and	NULL
used	NULL
to	NULL
normalize	NULL
for	NULL
differences	NULL
in	NULL
loading	NULL
and	NULL
transfer	NULL
among	NULL
samples	NULL
.	NULL

Western	NULL
Blotting	NULL
Analysis	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
lysing	NULL
10	NULL
``	NULL
cells	NULL
with	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
50	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
1	NULL
mm	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
mm	NULL
sodium	NULL
fluoride	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mm	NULL
DTT	NULL
,	NULL
1	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
1	NULL
x	NULL
Complete	NULL
(	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
;	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Protein	NULL
extracts	NULL
were	NULL
then	NULL
prepared	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Protein	NULL
concentration	NULL
in	NULL
each	NULL
supernatant	NULL
was	NULL
determined	NULL
by	NULL
using	NULL
a	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
Labora-tories	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Fifty	NULL
to	NULL
100	NULL
ug	NULL
of	NULL
total	NULL
protein	NULL
were	NULL
resolved	NULL
on	NULL
12	NULL
%	NULL
SDS-PAGE	NULL
gels	NULL
and	NULL
transferred	NULL
onto	NULL
Immobilon-P	NULL
membrane	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
}	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
blocked	NULL
with	NULL
4	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
in	NULL
PBS-T	NULL
(	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
in	NULL
PBS	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
After	NULL
washing	NULL
with	NULL
three	NULL
changes	NULL
of	NULL
PBS-T	NULL
for	NULL
30	NULL
min	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
primary	NULL
antibody	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
primary	NULL
antibodies	NULL
used	NULL
were	NULL
monoclonal	NULL
antibody	NULL
specific	NULL
for	NULL
ERK2	NULL
(	NULL
Transduction	NULL
Labora-tories	NULL
,	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
,	NULL
polyclonal	NULL
antibody	NULL
Anti-Active	NULL
MAPK	NULL
specific	NULL
for	NULL
the	NULL
dually	NULL
phosphorylated	NULL
and	NULL
activated	NULL
form	NULL
of	NULL
ERKs	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
and	NULL
polyclonal	NULL
antibody	NULL
specific	NULL
for	NULL
JNK1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
}	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
a	NULL
horseradish	NULL
peroxidase-conjugated	NULL
secondary	NULL
antibody	NULL
and	NULL
developed	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
assay	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
density	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
quantitated	NULL
using	NULL
a	NULL
densitom-eter	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Kinase	NULL
Activity	NULL
Assays	NULL
.	NULL

Kinase	NULL
activity	NULL
was	NULL
measured	NULL
after	NULL
immuno-precipitation	NULL
of	NULL
endogenous	NULL
JNK1	NULL
and	NULL
ERK2	NULL
according	NULL
to	NULL
Guyton	NULL
et	NULL
al	NULL
.	NULL

(	NULL
65	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
50	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
1	NULL
mm	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
mm	NULL
sodium	NULL
fluoride	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mm	NULL
DTT	NULL
,	NULL
1	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
1	NULL
%	NULL
Complete	NULL
(	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
;	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Protein	NULL
extracts	NULL
were	NULL
then	NULL
cleared	NULL
of	NULL
cellular	NULL
debris	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Cellular	NULL
ERK2	NULL
and	NULL
JNK1	NULL
were	NULL
immunoprecipitated	NULL
from	NULL
the	NULL
extract	NULL
using	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
p42°	NULL
``	NULL
_	NULL
``	NULL
or	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

Kinase	NULL
activity	NULL
was	NULL
assayed	NULL
for	NULL
20	NULL
min	NULL
at	NULL
30°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
30	NULL
um	NULL
ATP	NULL
,	NULL
20	NULL
uCi	NULL
of	NULL
[	NULL
y-°°PJATP	NULL
,	NULL
and	NULL
6	NULL
ug	NULL
of	NULL
substrate	NULL
in	NULL
assay	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
MOPS	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
20	NULL
mM	NULL
MgCis	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
.	NULL

The	NULL
substrate	NULL
used	NULL
for	NULL
measuring	NULL
ERK2	NULL
activity	NULL
was	NULL
MBP	NULL
,	NULL
and	NULL
the	NULL
substrate	NULL
used	NULL
for	NULL
measuring	NULL
JNK1	NULL
activity	NULL
was	NULL
GST-c-Jun	NULL
(	NULL
1-135	NULL
)	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
terminated	NULL
by	NULL
addition	NULL
of	NULL
Laemmli	NULL
buffer	NULL
and	NULL
boiling	NULL
samples	NULL
and	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
in	NULL
12	NULL
%	NULL
gels	NULL
.	NULL

Gels	NULL
were	NULL
then	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
and/or	NULL
quantitated	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

Kinase	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
amount	NULL
of	NULL
°°P	NULL
incorporated	NULL
onto	NULL
the	NULL
substrates	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
Thomas	NULL
Primiano	NULL
for	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
Eva	NULL
Szabo	NULL
for	NULL
human	NULL
c-jun	NULL
cDNA	NULL
probe	NULL
,	NULL
Dr.	NULL
Daniel	NULL
Nathans	NULL
for	NULL
human	NULL
c-fos	NULL
cDNA	NULL
probe	NULL
,	NULL
and	NULL
Dr.	NULL
Jim	NULL
Woodgett	NULL
for	NULL
GST-c-jun	NULL
(	NULL
1-135	NULL
)	NULL
construct	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Johnson	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
and	NULL
Villancourt	NULL
,	NULL
R.	NULL
R.	NULL
Sequential	NULL
protein	NULL
kinase	NULL
reac-	NULL
tions	NULL
controlling	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
6	NULL
:	NULL
230-238	NULL
,	NULL
1994	NULL
.	NULL

2	NULL
.	NULL

Marshall	NULL
,	NULL
C.	NULL
J.	NULL
Specificity	NULL
of	NULL
receptor	NULL
tyrosine	NULL
kinase	NULL
signaling	NULL
:	NULL
transient	NULL
versus	NULL
sustained	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
activation	NULL
.	NULL

Cell	NULL
,	NULL
80	NULL
:	NULL
179-185	NULL
,	NULL
1995	NULL
.	NULL

3	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
The	NULL
role	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
Jun	NULL
proteins	NULL
in	NULL
response	NULL
to	NULL
phorbol	NULL
ester	NULL
and	NULL
UV	NULL
light	NULL
.	NULL

in	NULL
:	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Inducible	NULL
Gene	NULL
Ex-pression	NULL
,	NULL
pp	NULL
.	NULL

63-92	NULL
.	NULL

Boston	NULL
:	NULL
Birkhauser	NULL
,	NULL
1995	NULL
.	NULL

4	NULL
.	NULL

Janknecht	NULL
,	NULL
R.	NULL
,	NULL
Cahill	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Nordheim	NULL
,	NULL
A	NULL
.	NULL

Signal	NULL
integration	NULL
at	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

Carcinogenesis	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

16	NULL
:	NULL
443-450	NULL
,	NULL
1995	NULL
.	NULL

5	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Berstein	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
Transcriptional	NULL
and	NULL
post-transcriptional	NULL
regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
:	NULL
3320-3323	NULL
,	NULL
1990	NULL
.	NULL

6	NULL
.	NULL

Szabo	NULL
,	NULL
E.	NULL
,	NULL
Preis	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Brown	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
and	NULL
Birrer	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

The	NULL
role	NULL
of	NULL
jun	NULL
and	NULL
fos	NULL
gene	NULL
family	NULL
members	NULL
in	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
induced	NULL
hemopoietic	NULL
differentiation	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

,	NULL
2	NULL
:	NULL
475-482	NULL
,	NULL
1991	NULL
.	NULL

7	NULL
.	NULL

Gaynor	NULL
,	NULL
R.	NULL
,	NULL
Simon	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Koeffler	NULL
,	NULL
P.	NULL
Expression	NULL
of	NULL
c-jun	NULL
during	NULL
macrophage	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

Blood	NULL
,	NULL
77	NULL
;	NULL
2618-2623	NULL
,	NULL
1991	NULL
.	NULL

8	NULL
.	NULL

Franklin	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Unlap	NULL
,	NULL
T.	NULL
,	NULL
Adler	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
Multiple	NULL
signal	NULL
transduction	NULL
pathways	NULL
mediate	NULL
c-Jun	NULL
protein	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

,	NULL
4	NULL
:	NULL
377-385	NULL
,	NULL
1993	NULL
.	NULL

9	NULL
.	NULL

Pulverer	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Avruch	NULL
,	NULL
J.	NULL
,	NULL
Nikolakaki	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
Phosphorylation	NULL
of	NULL
c-jun	NULL
mediated	NULL
by	NULL
MAP	NULL
kinases	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
353	NULL
:	NULL
670-674	NULL
,	NULL
1991	NULL
.	NULL

10	NULL
.	NULL

Pulverer	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Hughes	NULL
,	NULL
K.	NULL
,	NULL
Franklin	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Leevers	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
Co-purification	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
with	NULL
phorbol	NULL
ester-induced	NULL
c-Jun	NULL
kinase	NULL
activity	NULL
in	NULL
U937	NULL
leukaemic	NULL
cells	NULL
.	NULL

Oncogene	NULL
,	NULL
8	NULL
:	NULL
407-415	NULL
,	NULL
1993	NULL
.	NULL

11	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
The	NULL
regulation	NULL
of	NULL
AP-1	NULL
activity	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
:	NULL
16483-16486	NULL
,	NULL
1995	NULL
.	NULL

12	NULL
.	NULL

Blumer	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
G.	NULL
L.	NULL
Diversity	NULL
in	NULL
function	NULL
and	NULL
regulation	NULL
of	NULL
MAP	NULL
kinase	NULL
pathways	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
19	NULL
:	NULL
236-240	NULL
,	NULL
1994	NULL
.	NULL

13	NULL
.	NULL

Cobb	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
Goldsmith	NULL
,	NULL
E.	NULL
J	NULL
.	NULL

How	NULL
MAP	NULL
kinases	NULL
are	NULL
regulated	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
:	NULL
14843-14846	NULL
,	NULL
1995	NULL
.	NULL

14	NULL
.	NULL

Bokemeyer	NULL
,	NULL
D.	NULL
,	NULL
Sorokin	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Dunn	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

Multiple	NULL
intracellular	NULL
MAP	NULL
kinase	NULL
signaling	NULL
cascades	NULL
.	NULL

Kidney	NULL
Int	NULL
.	NULL

,	NULL
49	NULL
:	NULL
1187-1198	NULL
,	NULL
1996	NULL
.	NULL

15	NULL
.	NULL

Sturgill	NULL
,	NULL
T.	NULL
W.	NULL
,	NULL
and	NULL
Wu	NULL
,	NULL
J	NULL
.	NULL

Recent	NULL
progress	NULL
in	NULL
characterization	NULL
of	NULL
protein	NULL
kinase	NULL
cascades	NULL
for	NULL
phosphorylation	NULL
of	NULL
ribosomal	NULL
protein	NULL
S6	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1092	NULL
;	NULL
350-357	NULL
,	NULL
1991	NULL
.	NULL

16	NULL
.	NULL

Dérijard	NULL
,	NULL
B.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Wu	NULL
,	NULL
I.	NULL
,	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
Su	NULL
,	NULL
B.	NULL
,	NULL
Deng	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
J.	NULL
JNK1	NULL
:	NULL
a	NULL
protein	NULL
kinase	NULL
stimulated	NULL
by	NULL
UV	NULL
light	NULL
and	NULL
Ha-Ras	NULL
that	NULL
binds	NULL
and	NULL
phosphorylates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
,	NULL
76	NULL
:	NULL
1025-1037	NULL
,	NULL
1994	NULL
.	NULL

17	NULL
.	NULL

Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Banerjee	NULL
,	NULL
P.	NULL
,	NULL
Nikolakaki	NULL
,	NULL
E.	NULL
,	NULL
Dai	NULL
,	NULL
T.	NULL
,	NULL
Rubie	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Ahmad	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Avruch	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
The	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
subfamily	NULL
of	NULL
c-Jun	NULL
kinases	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
369	NULL
:	NULL
156-160	NULL
,	NULL
1994	NULL
.	NULL

18	NULL
.	NULL

Galcheva-Gargova	NULL
,	NULL
Z.	NULL
,	NULL
Dérijard	NULL
,	NULL
B.	NULL
,	NULL
Wu	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

An	NULL
osmo-sensing	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
,	NULL
DC	NULL
)	NULL
,	NULL
265	NULL
:	NULL
806-808	NULL
,	NULL
1994	NULL
.	NULL

19	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Bibbs	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

A	NULL
MAP	NULL
kinase	NULL
targeted	NULL
by	NULL
endotoxin	NULL
and	NULL
hyperosmolarity	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
,	NULL
DC	NULL
)	NULL
,	NULL
265	NULL
:	NULL
808-811	NULL
,	NULL
1994	NULL
.	NULL

20	NULL
.	NULL

Rouse	NULL
,	NULL
J.	NULL
,	NULL
Cohen	NULL
,	NULL
P.	NULL
,	NULL
Trigon	NULL
,	NULL
S.	NULL
,	NULL
Morgane	NULL
,	NULL
M.	NULL
,	NULL
Alonso-Llamazares	NULL
,	NULL
A.	NULL
,	NULL
Zamanillo	NULL
,	NULL
D.	NULL
,	NULL
Hunt	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Nebreda	NULL
,	NULL
A.	NULL
R.	NULL
A	NULL
novel	NULL
kinase	NULL
cascade	NULL
triggered	NULL
by	NULL
stress	NULL
and	NULL
heat	NULL
shock	NULL
that	NULL
stimulates	NULL
MAPKAP	NULL
kinase-2	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
small	NULL
heat	NULL
shock	NULL
proteins	NULL
.	NULL

Cell	NULL
,	NULL
78	NULL
:	NULL
1027-1037	NULL
,	NULL
1994	NULL
.	NULL

21	NULL
.	NULL

Morrison	NULL
,	NULL
D.	NULL
K.	NULL
Mechanisms	NULL
regulating	NULL
Raf-1	NULL
activity	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Mol	NULL
.	NULL

Reprod	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
42	NULL
:	NULL
507-514	NULL
,	NULL
1995	NULL
.	NULL

22	NULL
.	NULL

McCormick	NULL
,	NULL
F.	NULL
Ras-related	NULL
protein	NULL
in	NULL
signal	NULL
transduction	NULL
and	NULL
growth	NULL
control	NULL
.	NULL

Mol	NULL
.	NULL

Reprod	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
42	NULL
:	NULL
500-506	NULL
,	NULL
1995	NULL
.	NULL

23	NULL
.	NULL

Marshall	NULL
,	NULL
C.	NULL
J.	NULL
MAP	NULL
kinase	NULL
kinase	NULL
kinase	NULL
,	NULL
MAP	NULL
kinase	NULL
kinase	NULL
and	NULL
MAP	NULL
kinase	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
4	NULL
:	NULL
82-89	NULL
,	NULL
1994	NULL
.	NULL

24	NULL
.	NULL

Crews	NULL
,	NULL
C.	NULL
,	NULL
Alessandrini	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Erikson	NULL
,	NULL
R.	NULL
The	NULL
primary	NULL
structure	NULL
of	NULL
MEK	NULL
,	NULL
a	NULL
protein	NULL
kinase	NULL
that	NULL
phosphorylates	NULL
the	NULL
ERK	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
,	NULL
DC	NULL
)	NULL
,	NULL
258	NULL
:	NULL
478-480	NULL
,	NULL
1992	NULL
.	NULL

25	NULL
.	NULL

Kosako	NULL
,	NULL
H.	NULL
,	NULL
Gotoh	NULL
,	NULL
Y.	NULL
,	NULL
Matsuda	NULL
,	NULL
S.	NULL
,	NULL
Ishikawa	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Nishida	NULL
,	NULL
E.	NULL
Xenopus	NULL
MAP	NULL
kinase	NULL
activator	NULL
is	NULL
a	NULL
serine/threonine/tyrosine	NULL
kinases	NULL
activated	NULL
by	NULL
threonine	NULL
phosphorylation	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
17	NULL
:	NULL
2903-2908	NULL
,	NULL
1992	NULL
.	NULL

26	NULL
.	NULL

Kolch	NULL
,	NULL
W.	NULL
,	NULL
Heidecker	NULL
,	NULL
G.	NULL
,	NULL
Kochs	NULL
,	NULL
G.	NULL
,	NULL
Hummel	NULL
,	NULL
R.	NULL
,	NULL
Vahidi	NULL
,	NULL
H.	NULL
,	NULL
Mischak	NULL
,	NULL
H.	NULL
,	NULL
Finkenzeller	NULL
,	NULL
G.	NULL
,	NULL
Marmé	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
Protein	NULL
kinase	NULL
Ca	NULL
activates	NULL
RAF-1	NULL
by	NULL
direct	NULL
phosphorylation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
364	NULL
:	NULL
249-252	NULL
,	NULL
1993	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
27	NULL
.	NULL

Sozeri	NULL
,	NULL
O.	NULL
,	NULL
Vollmer	NULL
,	NULL
K.	NULL
,	NULL
Liyanage	NULL
,	NULL
M.	NULL
,	NULL
Frith	NULL
,	NULL
D.	NULL
,	NULL
Kour	NULL
,	NULL
G.	NULL
,	NULL
Mark	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
and	NULL
Stabel	NULL
,	NULL
S.	NULL
Activation	NULL
of	NULL
the	NULL
c-Raf	NULL
protein	NULL
kinase	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
phosphorylation	NULL
.	NULL

Oncogene	NULL
,	NULL
7	NULL
:	NULL
2259-2262	NULL
,	NULL
1992	NULL
.	NULL

28	NULL
.	NULL

Morrison	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
Heidecker	NULL
,	NULL
G.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
,	NULL
and	NULL
Copeland	NULL
,	NULL
T.	NULL
D.	NULL
Identification	NULL
of	NULL
the	NULL
major	NULL
phorsphorylation	NULL
sites	NULL
of	NULL
the	NULL
Raf-1	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
:	NULL
17309-17316	NULL
,	NULL
1993	NULL
.	NULL

29	NULL
.	NULL

Cowley	NULL
,	NULL
S.	NULL
,	NULL
Paterson	NULL
,	NULL
H.	NULL
,	NULL
Kemp	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Marshall	NULL
,	NULL
C.	NULL
J.	NULL
Activation	NULL
of	NULL
MAP	NULL
kinase	NULL
kinase	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
PC12	NULL
differentiation	NULL
and	NULL
for	NULL
transformation	NULL
of	NULL
NIH	NULL
3T3	NULL
cells	NULL
.	NULL

Cell	NULL
,	NULL
77	NULL
:	NULL
841-852	NULL
,	NULL
1994	NULL
.	NULL

30	NULL
.	NULL

Fukuda	NULL
,	NULL
M.	NULL
,	NULL
Gotoh	NULL
,	NULL
Y.	NULL
,	NULL
Tachibana	NULL
,	NULL
T.	NULL
,	NULL
Dell	NULL
,	NULL
K.	NULL
,	NULL
Hattori	NULL
,	NULL
S.	NULL
,	NULL
Yoneda	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Nishida	NULL
,	NULL
E.	NULL
Induction	NULL
of	NULL
neurite	NULL
outgrowth	NULL
by	NULL
MAP	NULL
kinase	NULL
in	NULL
PC12	NULL
cells	NULL
.	NULL

Oncogene	NULL
,	NULL
11	NULL
:	NULL
239-244	NULL
,	NULL
1995	NULL
.	NULL

31	NULL
.	NULL

Whalen	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Galasinski	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Shapiro	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Nahreini	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
and	NULL
Ahn	NULL
,	NULL
N.	NULL
G.	NULL
Megakaryocytic	NULL
differentiation	NULL
induced	NULL
by	NULL
constitutive	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
17	NULL
:	NULL
1947-1958	NULL
,	NULL
1997	NULL
.	NULL

32	NULL
.	NULL

Franklin	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
Constitutively	NULL
active	NULL
MAP	NULL
kinase	NULL
kinase	NULL
(	NULL
MEK1	NULL
)	NULL
stimulates	NULL
SAP	NULL
kinase	NULL
and	NULL
c-Jun	NULL
transcriptional	NULL
activity	NULL
in	NULL
U937	NULL
human	NULL
leukemic	NULL
cells	NULL
.	NULL

Oncogene	NULL
,	NULL
11	NULL
:	NULL
2365-2374	NULL
,	NULL
1995	NULL
.	NULL

33	NULL
.	NULL

Meighan-Mantha	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Wellstein	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Riegel	NULL
,	NULL
A.	NULL
T.	NULL
Differential	NULL
regulation	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
1	NULL
and	NULL
2	NULL
activity	NULL
during	NULL
12-O-tetradecanoylphorbol	NULL
13-acetate-induced	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

,	NULL
234	NULL
:	NULL
321-328	NULL
,	NULL
1997	NULL
.	NULL

34	NULL
.	NULL

Kozopas	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Buchan	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
and	NULL
Craig	NULL
,	NULL
R.	NULL
W.	NULL
Improved	NULL
coupling	NULL
between	NULL
proliferation-arrest	NULL
and	NULL
differentiation-induction	NULL
in	NULL
ML-1	NULL
human	NULL
myeloblastic	NULL
leukemia	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
145	NULL
:	NULL
575-586	NULL
,	NULL
1990	NULL
.	NULL

35	NULL
.	NULL

Minowada	NULL
,	NULL
J	NULL
.	NULL

Immunology	NULL
of	NULL
leukemic	NULL
cells	NULL
.	NULL

/n	NULL
:	NULL
F.	NULL
Gunz	NULL
and	NULL
E.	NULL
Henderson	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Leukemia	NULL
,	NULL
pp	NULL
.	NULL

119-139	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Grune	NULL
and	NULL
Stratton	NULL
.	NULL

1982	NULL
.	NULL

36	NULL
.	NULL

Takeda	NULL
,	NULL
K.	NULL
,	NULL
Minowada	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Bloch	NULL
,	NULL
A.	NULL
Kinetics	NULL
of	NULL
appearance	NULL
of	NULL
differentiation-associated	NULL
characteristics	NULL
in	NULL
ML-1	NULL
,	NULL
a	NULL
line	NULL
of	NULL
human	NULL
myeloblastic	NULL
leukemia	NULL
cells	NULL
,	NULL
after	NULL
treatment	NULL
with	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
,	NULL
dimethyl	NULL
sulfoxide	NULL
or	NULL
1-B-p-arabinofuranosylcytosine	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
42	NULL
:	NULL
5152-5158	NULL
,	NULL
1982	NULL
.	NULL

37	NULL
.	NULL

Craig	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Bloch	NULL
,	NULL
A	NULL
.	NULL

Early	NULL
decline	NULL
in	NULL
c-myb	NULL
oncogene	NULL
expression	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
human	NULL
myeloblastic	NULL
leukemia	NULL
(	NULL
ML-1	NULL
)	NULL
cells	NULL
induced	NULL
with	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
44	NULL
:	NULL
442-446	NULL
,	NULL
1984	NULL
.	NULL

38	NULL
.	NULL

Kozopas	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Yang	NULL
,	NULL
T.	NULL
,	NULL
Buchan	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Zhou	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Craig	NULL
,	NULL
R.	NULL
W.	NULL
MCL1	NULL
,	NULL
a	NULL
gene	NULL
expressed	NULL
in	NULL
programmed	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
,	NULL
has	NULL
sequence	NULL
similarity	NULL
to	NULL
BCL2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
:	NULL
3516-3520	NULL
,	NULL
1993	NULL
.	NULL

39	NULL
.	NULL

Rembish	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Craig	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Trush	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
in	NULL
vitro	NULL
model	NULL
for	NULL
assessing	NULL
mitochondrial	NULL
maturation	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Toxicologist	NULL
,	NULL
12	NULL
:	NULL
284	NULL
,	NULL
1992	NULL
.	NULL

40	NULL
.	NULL

Dudley	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
Pang	NULL
,	NULL
L.	NULL
,	NULL
Decker	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Bridges	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Saltiel	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

A	NULL
synthetic	NULL
inhibitor	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
:	NULL
7686-7689	NULL
,	NULL
1995	NULL
.	NULL

41	NULL
.	NULL

Alessi	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Cuenda	NULL
,	NULL
A.	NULL
,	NULL
Cohen	NULL
,	NULL
P.	NULL
,	NULL
Dudley	NULL
,	NULL
D.T	NULL
.	NULL

,	NULL
and	NULL
Saltiel	NULL
,	NULL
A.	NULL
R.	NULL
PD	NULL
098059	NULL
is	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
:	NULL
27489-27494	NULL
,	NULL
1995	NULL
.	NULL

42	NULL
.	NULL

Pang	NULL
,	NULL
L.	NULL
,	NULL
Sawada	NULL
,	NULL
T.	NULL
,	NULL
Decker	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Saltiel	NULL
,	NULL
A.	NULL
R.	NULL
Inhibition	NULL
of	NULL
MAP	NULL
kinase	NULL
kinase	NULL
blocks	NULL
the	NULL
differentiation	NULL
of	NULL
PC12	NULL
cells	NULL
induced	NULL
by	NULL
nerve	NULL
growth	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
:	NULL
13585-13588	NULL
,	NULL
1995	NULL
.	NULL

43	NULL
.	NULL

Yagisawa	NULL
,	NULL
M.	NULL
,	NULL
Yuo	NULL
,	NULL
A.	NULL
,	NULL
Yonemaru	NULL
,	NULL
M.	NULL
,	NULL
Imajoh-Ohmi	NULL
,	NULL
S.	NULL
,	NULL
Kanegasaki	NULL
,	NULL
S.	NULL
,	NULL
Yazaki	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Takaku	NULL
,	NULL
F.	NULL
Superoxide	NULL
release	NULL
and	NULL
NADPH	NULL
oxidase	NULL
components	NULL
in	NULL
mature	NULL
human	NULL
phagocytes	NULL
:	NULL
correlation	NULL
between	NULL
functional	NULL
capacity	NULL
and	NULL
amount	NULL
of	NULL
functional	NULL
proteins	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
228	NULL
:	NULL
510-516	NULL
,	NULL
1996	NULL
.	NULL

44	NULL
.	NULL

Takao	NULL
,	NULL
S.	NULL
,	NULL
Smith	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Wang	NULL
,	NULL
D.	NULL
,	NULL
Chan	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
Bulkley	NULL
,	NULL
G.	NULL
B.	NULL
,	NULL
and	NULL
Klein	NULL
,	NULL
A.	NULL
S.	NULL
Role	NULL
of	NULL
reactive	NULL
oxygen	NULL
metabolites	NULL
in	NULL
murine	NULL
peritoneal	NULL
macrophage	NULL
phagocytosis	NULL
and	NULL
phagocytic	NULL
killing	NULL
.	NULL

Am	NULL
.	NULL

J	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
277	NULL
:	NULL
C1278-C1284	NULL
,	NULL
1996	NULL
.	NULL

45	NULL
.	NULL

Makishima	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Honma	NULL
,	NULL
Y.	NULL
Ethacrynic	NULL
acid	NULL
and	NULL
1a	NULL
,	NULL
25-dihy-droxyvitamin	NULL
D3	NULL
cooperatively	NULL
inhibit	NULL
proliferation	NULL
and	NULL
induce	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
.	NULL

Leuk	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
20	NULL
:	NULL
781-789	NULL
,	NULL
1996	NULL
.	NULL

46	NULL
.	NULL

Nakagawara	NULL
,	NULL
A.	NULL
,	NULL
Nathan	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
and	NULL
Cohn	NULL
,	NULL
Z	NULL
.	NULL

A.	NULL
Hydrogen	NULL
peroxide	NULL
metabolism	NULL
in	NULL
human	NULL
monocytes	NULL
during	NULL
differentiation	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
68	NULL
:	NULL
1243-1252	NULL
,	NULL
1981	NULL
.	NULL

47	NULL
.	NULL

He	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Trush	NULL
,	NULL
M.	NULL
A.	NULL
Synergistic	NULL
effect	NULL
of	NULL
the	NULL
benzene	NULL
metabolite	NULL
hydroquinone	NULL
on	NULL
12-O-tetradecanoylphorbol	NULL
13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
-induced	NULL
human	NULL
myeloblastic	NULL
leukemia	NULL
cell	NULL
differentiation	NULL
.	NULL

Toxicologist	NULL
,	NULL
30	NULL
:	NULL
1694	NULL
,	NULL
1996	NULL
.	NULL

48	NULL
.	NULL

Cohn	NULL
,	NULL
Z	NULL
.	NULL

A	NULL
.	NULL

The	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
9	NULL
:	NULL
163-214	NULL
,	NULL
1968	NULL
.	NULL

49	NULL
.	NULL

Esterline	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Trush	NULL
,	NULL
M.	NULL
A.	NULL
Lucigenin	NULL
chemiluminescence	NULL
and	NULL
its	NULL
relationship	NULL
to	NULL
mitochondrial	NULL
respiration	NULL
in	NULL
phagocytic	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
159	NULL
;	NULL
584-591	NULL
,	NULL
1989	NULL
.	NULL

50	NULL
.	NULL

Rembish	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Trush	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Further	NULL
evidence	NULL
that	NULL
lucigenin-derived	NULL
chemiluminescence	NULL
monitors	NULL
mitochondrial	NULL
superoxide	NULL
generation	NULL
in	NULL
rat	NULL
alveolar	NULL
macrophages	NULL
.	NULL

Free	NULL
Radical	NULL
Biol	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
17	NULL
:	NULL
117-126	NULL
,	NULL
1994	NULL
.	NULL

51	NULL
.	NULL

Li	NULL
,	NULL
Y.	NULL
,	NULL
Zhu	NULL
,	NULL
H.	NULL
,	NULL
Kuppusamy	NULL
,	NULL
P.	NULL
,	NULL
Roubaud	NULL
,	NULL
V.	NULL
,	NULL
Zweier	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Trush	NULL
,	NULL
M.	NULL
A.	NULL
Validation	NULL
of	NULL
lucigenin	NULL
(	NULL
bis-N-methylacridinium	NULL
)	NULL
as	NULL
a	NULL
chemilumigenic	NULL
probe	NULL
for	NULL
detecting	NULL
superoxide	NULL
anion	NULL
radical	NULL
production	NULL
by	NULL
enzymatic	NULL
and	NULL
cellular	NULL
systems	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
273	NULL
:	NULL
2015-2023	NULL
,	NULL
1998	NULL
.	NULL

52	NULL
.	NULL

Clemens	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Trayner	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Menaya	NULL
,	NULL
J	NULL
.	NULL

The	NULL
role	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
isoenzymes	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

,	NULL
103	NULL
;	NULL
881-887	NULL
,	NULL
1992	NULL
.	NULL

53	NULL
.	NULL

Vandenbark	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Kuhn	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Niedel	NULL
,	NULL
J.	NULL
E.	NULL
Possible	NULL
mechanism	NULL
of	NULL
phorbol	NULL
ester-induced	NULL
maturation	NULL
of	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
73	NULL
:	NULL
448-457	NULL
,	NULL
1984	NULL
.	NULL

54	NULL
.	NULL

Nishikawa	NULL
,	NULL
M.	NULL
,	NULL
Uemura	NULL
,	NULL
Y.	NULL
,	NULL
Hidaka	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Shirakawa	NULL
,	NULL
S.	NULL
1-	NULL
(	NULL
5-Iso-quinone-linesulfony	NULL
}	NULL
)	NULL
-2-methypiperazine	NULL
(	NULL
H7	NULL
)	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
protein	NULL
kinases	NULL
,	NULL
inhibits	NULL
the	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
induced	NULL
by	NULL
phorbol	NULL
ester	NULL
.	NULL

Life	NULL
Sci	NULL
.	NULL

,	NULL
39	NULL
:	NULL
1101-1107	NULL
,	NULL
1986	NULL
.	NULL

55	NULL
.	NULL

Kiley	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
Parker	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

Differential	NULL
localization	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
isozymes	NULL
in	NULL
UQ37	NULL
cells	NULL
:	NULL
evidence	NULL
for	NULL
distinct	NULL
isozyme	NULL
functions	NULL
during	NULL
monocyte	NULL
differentiation	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

,	NULL
108	NULL
:	NULL
1003-1016	NULL
,	NULL
1995	NULL
.	NULL

56	NULL
.	NULL

Castagna	NULL
,	NULL
M.	NULL
,	NULL
Takai	NULL
,	NULL
Y.	NULL
,	NULL
Kaibuchi	NULL
,	NULL
K.	NULL
,	NULL
Sano	NULL
,	NULL
K.	NULL
,	NULL
Kiddawa	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

Direct	NULL
activation	NULL
of	NULL
calcium-activated	NULL
phospholipid-depen-dent	NULL
protein	NULL
kinase	NULL
by	NULL
tumor-promoting	NULL
phorbol	NULL
esters	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
257	NULL
:	NULL
7847-7851	NULL
,	NULL
1982	NULL
.	NULL

57	NULL
.	NULL

Niedel	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Kuhn	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Vandenbark	NULL
,	NULL
G.	NULL
R.	NULL
Phorbol	NULL
diester	NULL
receptor	NULL
copurified	NULL
with	NULL
protein	NULL
kinase	NULL
C.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
80	NULL
:	NULL
36-40	NULL
,	NULL
1983	NULL
.	NULL

58	NULL
.	NULL

Schultz	NULL
,	NULL
H.	NULL
,	NULL
Engel	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Gaestel	NULL
,	NULL
M.	NULL
PMA-induced	NULL
activation	NULL
of	NULL
the	NULL
p42/445	NULL
``	NULL
``	NULL
-	NULL
and	NULL
p38	NULL
``	NULL
``	NULL
-Mapk	NULL
kinase	NULL
cascades	NULL
in	NULL
HL-60	NULL
cells	NULL
is	NULL
PKC	NULL
dependent	NULL
but	NULL
not	NULL
essential	NULL
for	NULL
differentiation	NULL
to	NULL
the	NULL
macrophage-like	NULL
phenotype	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Physiol	NULL
.	NULL

,	NULL
173	NULL
:	NULL
310-318	NULL
,	NULL
1997	NULL
.	NULL

59	NULL
.	NULL

Alberola-lla	NULL
,	NULL
J.	NULL
,	NULL
Forbush	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Seger	NULL
,	NULL
R.	NULL
,	NULL
Krebs	NULL
,	NULL
E.	NULL
G.	NULL
,	NULL
and	NULL
Perimut-ter	NULL
,	NULL
R.	NULL
M.	NULL
Selective	NULL
requirement	NULL
for	NULL
MAP	NULL
kinase	NULL
activation	NULL
in	NULL
thymocyte	NULL
differentiation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
373	NULL
:	NULL
620-623	NULL
,	NULL
1995	NULL
.	NULL

60	NULL
.	NULL

Crompton	NULL
,	NULL
T.	NULL
,	NULL
Gilmour	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
and	NULL
Owen	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

The	NULL
MAP	NULL
kinase	NULL
pathway	NULL
controls	NULL
differentiation	NULL
from	NULL
double-negative	NULL
to	NULL
double-positive	NULL
thymocyte	NULL
.	NULL

Cell	NULL
,	NULL
86	NULL
:	NULL
243-251	NULL
,	NULL
1996	NULL
.	NULL

61	NULL
.	NULL

Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
Saleem	NULL
,	NULL
A.	NULL
,	NULL
Emoto	NULL
,	NULL
Y.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Activation	NULL
of	NULL
Raf-1	NULL
and	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
269	NULL
:	NULL
872-878	NULL
,	NULL
1994	NULL
.	NULL

62	NULL
.	NULL

Kensler	NULL
,	NULL
T.	NULL
W.	NULL
,	NULL
and	NULL
Trush	NULL
,	NULL
M.	NULL
A.	NULL
Inhibition	NULL
of	NULL
phorbol	NULL
ester-stimulated	NULL
chemiluminescence	NULL
in	NULL
human	NULL
polymorphonuclear	NULL
leukocytes	NULL
by	NULL
retinoic	NULL
acid	NULL
and	NULL
5	NULL
,	NULL
G-epoxyretinoic	NULL
acid	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
47	NULL
:	NULL
216-222	NULL
,	NULL
1981	NULL
.	NULL

63	NULL
.	NULL

Ennist	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Jones	NULL
,	NULL
K.	NULL
H.	NULL
Rapid	NULL
methods	NULL
for	NULL
identification	NULL
of	NULL
macrophages	NULL
in	NULL
suspension	NULL
by	NULL
acid	NULL
anaththy	NULL
!	NULL

acetate	NULL
esterase	NULL
activity	NULL
.	NULL

J.	NULL
Histochem	NULL
.	NULL

Cytochem	NULL
.	NULL

,	NULL
37	NULL
:	NULL
960-963	NULL
,	NULL
1983	NULL
.	NULL

64	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-choloform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Bio-chem	NULL
.	NULL

,	NULL
162	NULL
:	NULL
156-159	NULL
,	NULL
1987	NULL
.	NULL

65	NULL
.	NULL

Guyton	NULL
,	NULL
K.	NULL
Z.	NULL
,	NULL
Liu	NULL
,	NULL
Y.	NULL
,	NULL
Gorospe	NULL
,	NULL
M.	NULL
,	NULL
Xu	NULL
,	NULL
Q.	NULL
,	NULL
and	NULL
Holbrook	NULL
,	NULL
N.	NULL
J.	NULL
Activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
by	NULL
H	NULL
,	NULL
O	NULL
:	NULL
role	NULL
in	NULL
cell	NULL
survival	NULL
following	NULL
oxidant	NULL
injury	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
:	NULL
4138-4142	NULL
,	NULL
1996	NULL
.	NULL

315	NULL

